Details of Drug

Drug General Information (ID: D1383)
Drug Name	Ranolazine
Drug Type	Small molecule
Drug Synonymous	RANOLAZINE; 95635-55-5; Ranexa; N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide; CVT-303; (-)-Ranolazine; Ranolazine (Ranexa); Ranolazine 2HCl; RS-43285-003; 142387-99-3; N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide; CHEBI:87690; N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide; C24H33N3O4; NCGC00015897-02; DSSTox_RID_80743; DSSTox_CID_25196; DSSTox_GSID_45196; Ran4; CVT 303; Latixa; RAN D; Latixa; Ranolazine dihydrochloride; KEG-1295; RS-43285; Ranexa (TN); Ranexa, Ranolazine; Ranolazine (USAN/INN); Ranolazine extended-release; Ranolazine/Dronedarone Fixed-Dose Combination Click to Show/Hide
Disease Class	BA40: Angina pectoris; BC81: Supraventricular tachyarrhythmia
Therapeutic Class	Analgesics
Structure
Structure	3D Structure		2D Structure
Formula	C24H33N3O4
InChI	1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)
InChIKey	XKLMZUWKNUAPSZ-UHFFFAOYSA-N
Canonical SMILES	CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
External Link
	Pubchem ID	56959
	CAS Number	95635-55-5
	CHEBI ID	87690
	TTD ID	D03HYQ
	INTEDE ID	DR1394
	VARIDT ID	DR00246

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM010 Transporter inhibition BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM042 Additive hypotensive effects BM076 Increased risk of prolong QT interval BM081 Increased risk of ventricular arrhythmias BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Ranolazine
Affected cellular transport
	Transporter inhibition					Drug Num: 34
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0171		Berotralstat	C30H26F4N6O	137528262	Major		Inter Info	[38]
D0176		Betrixaban	C23H22ClN5O3	10275777	Major		Inter Info	[39], [40], [41]
D0551		Edoxaban	C24H30ClN7O4S	10280735	Major		Inter Info	[4], [70], [71], [72]
D1688		Venetoclax	C45H50ClN7O7S	49846579	Major		Inter Info	[3], [4], [204]
D0044		Alpelisib	C19H22F3N5O2S	56649450	Moderate		Inter Info	[1]
D0182		Binimetinib	C17H15BrF2N4O3	10288191	Moderate		Inter Info	[3], [4], [276]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[281], [282]
D0251		Capmatinib	C23H17FN6O	25145656	Moderate		Inter Info	[1]
D0412		Dalfampridine	C5H6N2	1727	Moderate		Inter Info	[3], [4], [124]
D0429		Daunorubicin	C27H29NO10	30323	Moderate		Inter Info	[383], [384], [385], [386]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Moderate		Inter Info	[383], [385], [386]
D0590		Erdafitinib	C25H30N6O2	67462786	Moderate		Inter Info	[425]
D0640		Felodipine	C18H19Cl2NO4	3333	Moderate		Inter Info	[1]
D0788		Idarubicin	C26H27NO9	42890	Moderate		Inter Info	[383], [384], [385], [386]
D0866		Istradefylline	C20H24N4O4	5311037	Moderate		Inter Info	[1]
D0869		Ivacaftor	C24H28N2O3	16220172	Moderate		Inter Info	[1]
D0897		Lasmiditan	C19H18F3N3O2	11610526	Moderate		Inter Info	[441]
D0898		Ledipasvir	C49H54F2N8O6	67505836	Moderate		Inter Info	[1]
D0963		Lusutrombopag	C29H32Cl2N2O5S	49843517	Moderate		Inter Info	[7]
D1130		Nicardipine	C26H29N3O6	4474	Moderate		Inter Info	[1]
D1134		Nifedipine	C17H18N2O6	4485	Moderate		Inter Info	[1]
D1313		Ponatinib	C29H27F3N6O	24826799	Moderate		Inter Info	[1]
D1348		Progesterone	C21H30O2	5994	Moderate		Inter Info	[1]
D1407		Rimegepant	C28H28F2N6O3	51049968	Moderate		Inter Info	[482]
D1423		Rolapitant	C25H26F6N2O2	10311306	Moderate		Inter Info	[74]
D1445		Sarecycline	C24H29N3O8	54681908	Moderate		Inter Info	[1]
D1501		Spironolactone	C24H32O4S	5833	Moderate		Inter Info	[1]
D1524		Suvorexant	C23H23ClN6O2	24965990	Moderate		Inter Info	[1]
D1532		Talazoparib	C19H14F2N6O	135565082	Moderate		Inter Info	[4], [496]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Moderate		Inter Info	[1]
D1608		Tolvaptan	C26H25ClN2O3	216237	Moderate		Inter Info	[506]
D1664		Ulipristal	C28H35NO3	13559281	Moderate		Inter Info	[1]
D1919		Varenicline	C13H13N3	170361	Moderate		Inter Info	[4], [1], [516]
D0658		Fidaxomicin	C52H74Cl2O18	10034073	Minor		Inter Info	[3], [4], [526]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 176
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0597		Erythromycin	C37H67NO13	12560	Major		Inter Info	[1]
D0667		Fluconazole	C13H12F2N6O	3365	Major		Inter Info	[1]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Major		Inter Info	[1]
D0799		Indinavir	C36H47N5O4	5362440	Major		Inter Info	[3], [4], [1], [10]
D0956		Lovastatin	C24H36O5	53232	Major		Inter Info	[4], [11], [12], [13], [14], [1], [15], [16], [17], [18], [19]
D1119		Nelfinavir	C32H45N3O4S	64143	Major		Inter Info	[3], [4], [1], [10]
D0080		Amprenavir	C25H35N3O6S	65016	Major		Inter Info	[3], [4], [1], [10]
D0100		Aprepitant	C23H21F7N4O3	135413536	Major		Inter Info	[1]
D0116		Atazanavir	C38H52N6O7	148192	Major		Inter Info	[3], [4], [1], [10]
D0120		Atorvastatin	C33H35FN2O5	60823	Major		Inter Info	[4], [33], [13], [1], [17], [18]
D0161		Benzhydrocodone	C25H25NO4	49836084	Major		Inter Info	[35], [36], [37]
D0192		Boceprevir	C27H45N5O5	10324367	Major		Inter Info	[3], [4], [1], [10]
D0202		Brexpiprazole	C25H27N3O2S	11978813	Major		Inter Info	[42]
D0349		Clarithromycin	C38H69NO13	84029	Major		Inter Info	[3], [4], [1], [10]
D0367		Clotrimazole	C22H17ClN2	2812	Major		Inter Info	[1]
D0375		Cobicistat	C40H53N7O5S2	25151504	Major		Inter Info	[3], [4], [1], [10]
D0386		Conivaptan	C32H26N4O2	151171	Major		Inter Info	[1]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[1]
D0413		Dalfopristin	C34H50N4O9S	6323289	Major		Inter Info	[65], [1]
D0426		Darunavir	C27H37N3O7S	213039	Major		Inter Info	[3], [4], [1], [10]
D0439		Delavirdine	C22H28N6O3S	5625	Major		Inter Info	[3], [4], [1], [10]
D0497		Diltiazem	C22H26N2O4S	39186	Major		Inter Info	[1]
D0543		Duvelisib	C22H17ClN6O	50905713	Major		Inter Info	[1]
D0559		Eliglustat	C23H36N2O4	23652731	Major		Inter Info	[73], [74]
D0638		Fedratinib	C27H36N6O3S	16722836	Major		Inter Info	[1]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Major		Inter Info	[3], [4], [1], [10]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Major		Inter Info	[1]
D0696		Fosnetupitant	C31H35F6N4O5P	71544786	Major		Inter Info	[65], [1]
D0789		Idelalisib	C22H18FN7O	11625818	Major		Inter Info	[3], [4], [1], [10]
D0793		Imatinib	C29H31N7O	5291	Major		Inter Info	[1]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Major		Inter Info	[1]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Major		Inter Info	[3], [4], [1], [10]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Major		Inter Info	[3], [4], [1], [10]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Major		Inter Info	[1]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[120]
D0901		Lemborexant	C22H20F2N4O2	56944144	Major		Inter Info	[3], [121]
D0906		Letermovir	C29H28F4N4O4	45138674	Major		Inter Info	[1]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Major		Inter Info	[3], [4], [1], [10]
D1117		Nefazodone	C25H32ClN5O2	4449	Major		Inter Info	[3], [4], [1], [10]
D1127		Netupitant	C30H32F6N4O	6451149	Major		Inter Info	[65], [1]
D1169		Oliceridine	C22H30N2O2S	66553195	Major		Inter Info	[138], [74]
D1203		Oxycodone	C18H21NO4	5284603	Major		Inter Info	[3], [4], [140]
D1315		Posaconazole	C37H42F2N8O4	468595	Major		Inter Info	[3], [4], [1], [10]
D1388		Relugolix	C29H27F2N7O5S	10348973	Major		Inter Info	[152]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[2], [3], [4], [153], [154], [155], [7]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[3], [4], [1], [10]
D1473		Simvastatin	C25H38O5	54454	Major		Inter Info	[4], [11], [12], [13], [1], [15], [16], [17], [18], [19]
D1533		Tamoxifen	C26H29NO	2733526	Major		Inter Info	[164], [165], [166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [74], [190], [191], [192], [193], [194], [195], [196], [197]
D1541		Telaprevir	C36H53N7O6	3010818	Major		Inter Info	[3], [4], [1], [10]
D1544		Telithromycin	C43H65N5O10	3002190	Major		Inter Info	[3], [4], [1], [10]
D1660		Tucatinib	C26H24N8O2	51039094	Major		Inter Info	[3], [4], [1], [10]
D1690		Verapamil	C27H38N2O4	2520	Major		Inter Info	[1]
D1706		Voriconazole	C16H14F3N5O	71616	Major		Inter Info	[3], [4], [1], [10]
D1709		Voxelotor	C19H19N3O3	71602803	Major		Inter Info	[1]
D0074		Amphetamine	C9H13N	3007	Moderate		Inter Info	[1]
D0308		Cevimeline	C10H17NOS	83898	Moderate		Inter Info	[213]
D0402		Cyclosporine	C62H111N11O12	5284373	Moderate		Inter Info	[1]
D1061		Midodrine	C12H18N2O4	4195	Moderate		Inter Info	[1]
D0006		Abemaciclib	C27H32F2N8	46220502	Moderate		Inter Info	[244]
D0008		Acalabrutinib	C26H23N7O2	71226662	Moderate		Inter Info	[245], [246]
D0035		Alfentanil	C21H32N6O3	51263	Moderate		Inter Info	[253], [254], [4], [202], [255], [256], [257], [258], [259], [260], [261], [262], [246], [263], [264], [265], [266]
D0038		Aliskiren	C30H53N3O6	5493444	Moderate		Inter Info	[2], [4], [267], [268]
D0096		Apixaban	C25H25N5O4	10182969	Moderate		Inter Info	[4], [269], [246]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[270]
D0119		Atomoxetine	C17H21NO	54841	Moderate		Inter Info	[272], [246], [273]
D0129		Avapritinib	C26H27FN10	118023034	Moderate		Inter Info	[4], [274]
D0133		Axitinib	C22H18N4OS	6450551	Moderate		Inter Info	[4], [275]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[4], [280]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[3], [4], [283]
D0215		Budesonide	C25H34O6	5281004	Moderate		Inter Info	[284], [3], [4], [285], [286], [287], [288], [289], [290], [291], [292], [293], [294], [295], [296], [297]
D0216		Budesonide (nasal)	C25H34O6	5281004	Moderate		Inter Info	[284], [3], [4]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[305]
D0262		Cariprazine	C21H32Cl2N4O	11154555	Moderate		Inter Info	[4], [307]
D0267		Carvedilol	C24H26N2O4	2585	Moderate		Inter Info	[1]
D0303		Cerivastatin	C26H34FNO5	446156	Moderate		Inter Info	[308], [309], [310], [311], [312], [313], [314], [315], [316], [317], [318], [319], [320], [321], [322], [323], [324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [342], [343], [344], [345], [346], [13], [347], [348], [349], [350], [351], [352], [353], [14], [246], [15], [354], [355], [356], [357], [358], [359], [360], [361], [362], [363], [364], [365], [366]
D0323		Chlorpheniramine	C16H19ClN2	2725	Moderate		Inter Info	[1]
D0370		Clozapine	C18H19ClN4	135398737	Moderate		Inter Info	[1]
D0376		Cobimetinib	C21H21F3IN3O2	16222096	Moderate		Inter Info	[368]
D0379		Codeine	C18H21NO3	5284371	Moderate		Inter Info	[369], [370], [371], [372], [373], [374], [74], [375], [376], [377], [378], [379], [380]
D0389		Copanlisib	C23H28N8O4	135565596	Moderate		Inter Info	[381]
D0424		Darifenacin	C28H30N2O2	444031	Moderate		Inter Info	[382], [246]
D0457		Dexfenfluramine	C12H16F3N	66265	Moderate		Inter Info	[1]
D0466		Dextromethorphan	C18H25NO	5360696	Moderate		Inter Info	[3], [4], [387], [141], [246], [388]
D0467		Dextropropoxyphene	C22H29NO2	10100	Moderate		Inter Info	[1]
D0494		Dihydroergotamine	C33H37N5O5	10531	Moderate		Inter Info	[389], [390], [391], [392], [393], [321], [394], [395], [396], [397], [398], [399], [400], [401], [402], [403], [404], [405], [406], [407], [408], [409], [410], [411], [412]
D0502		Diphenhydramine	C17H21NO	3100	Moderate		Inter Info	[1]
D0511		Docetaxel	C43H53NO14	148124	Moderate		Inter Info	[413], [3], [4], [414], [415], [416], [417], [418], [419]
D0539		Duloxetine	C18H19NOS	60835	Moderate		Inter Info	[420], [421]
D0592		Ergometrine	C19H23N3O2	443884	Moderate		Inter Info	[395], [397], [408]
D0593		Ergotamine	C33H35N5O5	8223	Moderate		Inter Info	[389], [390], [391], [392], [393], [321], [394], [395], [396], [397], [398], [399], [400], [401], [402], [403], [404], [405], [406], [407], [408], [409], [410], [411], [412]
D0629		Everolimus	C53H83NO14	6442177	Moderate		Inter Info	[427], [246]
D0641		Fenfluramine	C12H16F3N	3337	Moderate		Inter Info	[1]
D0646		Fentanyl	C22H28N2O	3345	Moderate		Inter Info	[429], [1]
D0655		Fesoterodine	C26H37NO3	6918558	Moderate		Inter Info	[430]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[431]
D0707		Galantamine	C17H21NO3	9651	Moderate		Inter Info	[1]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[4], [432]
D0739		Grazoprevir	C38H50N6O9S	44603531	Moderate		Inter Info	[433], [434]
D0745		Guanfacine	C9H9Cl2N3O	3519	Moderate		Inter Info	[4], [435]
D0785		Ibrutinib	C25H24N6O2	24821094	Moderate		Inter Info	[436], [246]
D0845		Irinotecan	C33H38N4O6	60838	Moderate		Inter Info	[2], [3], [4], [437], [438], [439], [440]
D0846		Irinotecan (liposomal)	C33H38N4O6	60838	Moderate		Inter Info	[3], [4], [437]
D0944		Lomitapide	C39H37F6N3O2	9853053	Moderate		Inter Info	[443]
D0959		Lumateperone	C24H28FN3O	21302490	Moderate		Inter Info	[446]
D0961		Lurasidone	C28H36N4O2S	213046	Moderate		Inter Info	[3], [4], [447], [246]
D0962		Lurbinectedin	C41H44N4O10S	57327016	Moderate		Inter Info	[448]
D0966		Macitentan	C19H20Br2N6O4S	16004692	Moderate		Inter Info	[449]
D0980		Maraviroc	C29H41F2N5O	3002977	Moderate		Inter Info	[450]
D1012		Metamfetamine	C10H15N	10836	Moderate		Inter Info	[1]
D1037		Methylergometrine	C20H25N3O2	8226	Moderate		Inter Info	[395], [397], [408]
D1043		Methysergide	C21H27N3O2	9681	Moderate		Inter Info	[395], [397], [408]
D1049		Metoprolol	C15H25NO3	4171	Moderate		Inter Info	[1]
D1054		Mexiletine	C11H17NO	4178	Moderate		Inter Info	[1]
D1057		Miconazole	C18H14Cl4N2O	4189	Moderate		Inter Info	[451]
D1060		Midazolam	C18H13ClFN3	4192	Moderate		Inter Info	[429], [1]
D1101		Naldemedine	C32H34N4O6	54732242	Moderate		Inter Info	[4], [453]
D1114		Nebivolol	C22H25F2NO4	71301	Moderate		Inter Info	[1]
D1139		Nintedanib	C31H33N5O4	135423438	Moderate		Inter Info	[454]
D1143		Nitisinone	C14H10F3NO5	115355	Moderate		Inter Info	[2], [3], [4]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[459]
D1194		Oxamniquine	C14H21N3O3	4612	Moderate		Inter Info	[1]
D1214		Palbociclib	C24H29N7O2	5330286	Moderate		Inter Info	[4], [460]
D1229		Paroxetine	C19H20FNO3	43815	Moderate		Inter Info	[1]
D1242		Pemigatinib	C24H27F2N5O4	86705695	Moderate		Inter Info	[4], [461]
D1293		Pindolol	C14H20N2O2	4828	Moderate		Inter Info	[1]
D1299		Pirfenidone	C12H11NO	40632	Moderate		Inter Info	[4], [468], [74]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[4], [65], [1], [469]
D1306		Polatuzumab vedotin	NA	NA	Moderate		Inter Info	[470]
D1324		Pralsetinib	C27H32FN9O2	129073603	Moderate		Inter Info	[471]
D1357		Propranolol	C16H21NO2	4946	Moderate		Inter Info	[1]
D1408		Riociguat	C20H19FN8O2	11304743	Moderate		Inter Info	[3], [4], [483]
D1409		Ripretinib	C24H21BrFN5O2	71584930	Moderate		Inter Info	[3], [484]
D1417		Rivaroxaban	C19H18ClN3O5S	9875401	Moderate		Inter Info	[485]
D1460		Selumetinib	C17H15BrClFN4O3	10127622	Moderate		Inter Info	[489]
D1466		Silodosin	C25H32F3N3O4	5312125	Moderate		Inter Info	[490]
D1476		Sirolimus	C51H79NO13	5284616	Moderate		Inter Info	[429], [1]
D1496		Sonidegib	C26H26F3N3O3	24775005	Moderate		Inter Info	[493]
D1505		Stiripentol	C14H18O3	5311454	Moderate		Inter Info	[4], [202], [495]
D1512		Sufentanil	C22H30N2O2S	41693	Moderate		Inter Info	[429], [1]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[429], [1]
D1534		Tamsulosin	C20H28N2O5S	129211	Moderate		Inter Info	[497], [498], [499], [74]
D1585		Timolol	C13H24N4O3S	33624	Moderate		Inter Info	[1]
D1586		Timolol (ophthalmic)	C13H24N4O3S	33624	Moderate		Inter Info	[503], [504], [505]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[4], [507], [508]
D1663		Ubrogepant	C29H26F3N5O3	68748835	Moderate		Inter Info	[515]
D1697		Vinblastine	C46H58N4O9	13342	Moderate		Inter Info	[429], [1]
D1698		Vincristine	C46H56N4O10	5978	Moderate		Inter Info	[429], [1]
D1699		Vincristine (liposome)	C46H56N4O10	5978	Moderate		Inter Info	[429], [1]
D1700		Vinorelbine	C45H54N4O8	5311497	Moderate		Inter Info	[429], [1]
D1718		Zanubrutinib	C27H29N5O3	135565884	Moderate		Inter Info	[517]
D1465		Sildenafil	C22H30N6O4S	135398744	Moderate		Inter Info	[518], [519], [520], [521]
D0220		Bupropion	C13H18ClNO	444	Minor		Inter Info	[1]
D0298		Celecoxib	C17H14F3N3O2S	2662	Minor		Inter Info	[1]
D0337		Cimetidine	C10H16N6S	2756	Minor		Inter Info	[1]
D0338		Cinacalcet	C22H22F3N	156419	Minor		Inter Info	[1]
D0351		Clemastine	C21H26ClNO	26987	Minor		Inter Info	[1]
D0356		Clobazam	C16H13ClN2O2	2789	Minor		Inter Info	[1]
D0397		Cyclizine	C18H22N2	6726	Minor		Inter Info	[1]
D0400		Cyclophosphamide	C7H15Cl2N2O2P	2907	Minor		Inter Info	[4]
D0409		Dacomitinib	C24H25ClFN5O2	11511120	Minor		Inter Info	[1]
D0425		Darolutamide	C19H19ClN6O2	67171867	Minor		Inter Info	[522]
D0516		Donepezil	C24H29NO3	3152	Minor		Inter Info	[486], [74], [523], [524]
D0518		Doravirine	C17H11ClF3N5O3	58460047	Minor		Inter Info	[525]
D0713		Gefitinib	C22H24ClFN4O3	123631	Minor		Inter Info	[1]
D0724		Givosiran	C78H139N11O30	119058042	Minor		Inter Info	[1]
D0732		Glycerol phenylbutyrate	C33H38O6	10482134	Minor		Inter Info	[1]
D0952		Lorcaserin	C11H14ClN	11658860	Minor		Inter Info	[1]
D1074		Mirabegron	C21H24N4O2S	9865528	Minor		Inter Info	[1]
D1104		Naloxegol	C34H53NO11	56959087	Minor		Inter Info	[530]
D1291		Pimecrolimus (topical)	C43H68ClNO11	6509979	Minor		Inter Info	[531]
D1428		Ropivacaine	C17H26N2O	175805	Minor		Inter Info	[532], [533], [534], [535], [536], [537], [538]
D1434		Ruxolitinib	C17H18N6	25126798	Minor		Inter Info	[4], [539]
D1553		Terbinafine	C21H25N	1549008	Minor		Inter Info	[1]
D1607		Tolterodine	C22H31NO	443879	Minor		Inter Info	[544], [545], [74]
D1649		Tripelennamine	C16H21N3	5587	Minor		Inter Info	[1]
D1581		Ticlopidine	C14H14ClNS	5472	Minor		Inter Info	[1]
	CYP450 enzyme induction					Drug Num: 41
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0224		Butabarbital	C10H16N2O3	2479	Major		Inter Info	[1]
D0225		Butalbital	C11H16N2O3	2481	Major		Inter Info	[1]
D1128		Nevirapine	C15H14N4O	4463	Major		Inter Info	[1]
D0061		Aminoglutethimide	C13H16N2O2	2145	Major		Inter Info	[1]
D0071		Amobarbital	C11H18N2O3	2164	Major		Inter Info	[1]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Major		Inter Info	[1]
D0106		Armodafinil	C15H15NO2S	9690109	Major		Inter Info	[1]
D0178		Bexarotene	C24H28O2	82146	Major		Inter Info	[1]
D0194		Bosentan	C27H29N5O6S	104865	Major		Inter Info	[1]
D0300		Cenobamate	C10H10ClN5O2	11962412	Major		Inter Info	[1]
D0453		Dexamethasone	C22H29FO5	5743	Major		Inter Info	[1]
D0554		Efavirenz	C14H9ClF3NO2	64139	Major		Inter Info	[1]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Major		Inter Info	[1]
D0628		Etravirine	C20H15BrN6O	193962	Major		Inter Info	[1]
D0639		Felbamate	C11H14N2O4	3331	Major		Inter Info	[1]
D0697		Fosphenytoin	C16H15N2O6P	56339	Major		Inter Info	[1]
D0741		Griseofulvin	C17H17ClO6	441140	Major		Inter Info	[1]
D0953		Lorlatinib	C21H19FN6O2	71731823	Major		Inter Info	[1]
D0958		Lumacaftor	C24H18F2N2O5	16678941	Major		Inter Info	[123], [1]
D1040		Methylphenobarbital	C13H14N2O3	8271	Major		Inter Info	[123], [1]
D1078		Mitotane	C14H10Cl4	4211	Major		Inter Info	[1]
D1081		Modafinil	C15H15NO2S	4236	Major		Inter Info	[1]
D1099		Nafcillin	C21H22N2O5S	8982	Major		Inter Info	[1]
D1198		Oxcarbazepine	C15H12N2O2	34312	Major		Inter Info	[1]
D1248		Pentobarbital	C11H18N2O3	4737	Major		Inter Info	[1]
D1265		Phenobarbital	C12H12N2O3	4763	Major		Inter Info	[1]
D1274		Phenylbutazone	C19H20N2O2	4781	Major		Inter Info	[1]
D1340		Primidone	C12H14N2O2	4909	Major		Inter Info	[1]
D1399		Rifabutin	C46H62N4O11	135398743	Major		Inter Info	[1]
D1400		Rifampicin	C43H58N4O12	135398735	Major		Inter Info	[123], [1]
D1401		Rifapentine	C47H64N4O12	135403821	Major		Inter Info	[1]
D1453		Secobarbital	C12H18N2O3	5193	Major		Inter Info	[1]
D1502		St. John's Wort	NA	NA	Major		Inter Info	[1]
D1518		Sulfinpyrazone	C23H20N2O3S	5342	Major		Inter Info	[1]
D1538		Tazemetostat	C34H44N4O4	66558664	Major		Inter Info	[1]
D1652		Troglitazone	C24H27NO5S	5591	Major		Inter Info	[1]
D0545		Echinacea	NA	NA	Moderate		Inter Info	[3], [422]
D1493		Somapacitan	C54H95N13O20S2	129894493	Moderate		Inter Info	[3], [4], [491]
D1495		Somatrem	C43H72N14O14	5487805	Moderate		Inter Info	[3], [4], [492], [491]
D1546		Telotristat ethyl	C27H26ClF3N6O3	25181577	Moderate		Inter Info	[4], [500]
D1494		Somatotropin	NA	NA	Moderate		Inter Info	[3], [4], [491]
Pharmacodynamic additive effects
	Additive hypotensive effects					Drug Num: 6
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0245		Canagliflozin	C24H25FO5S	24812758	Moderate		Inter Info	[3], [4], [306]
D0418		Dapagliflozin	C21H25ClO6	9887712	Moderate		Inter Info	[3], [4], [306]
D0565		Empagliflozin	C23H27ClO7	11949646	Moderate		Inter Info	[3], [4], [306]
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[2], [3], [4], [442], [7]
D1148		Nitrous acid	HNO2	24529	Moderate		Inter Info	[455], [456], [457]
D1251		Pentoxifylline	C13H18N4O3	4740	Moderate		Inter Info	[462]
	Increased risk of prolong QT interval					Drug Num: 142
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[2], [3], [4], [5], [6], [7], [8]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[2], [3], [4], [9]
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[2], [3], [4], [20], [21], [22], [23], [24], [25], [26], [27], [28], [7]
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[29]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[2], [3], [4], [30]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[34]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[2], [3], [4], [20], [21], [22], [23], [24], [25], [26], [27], [28], [7]
D0320		Chloroquine	C18H26ClN3	2719	Major		Inter Info	[43], [4], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61]
D0342		Cisapride	C23H29ClFN3O4	6917698	Major		Inter Info	[2], [3], [4], [62], [63], [64]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[2], [3], [4], [20], [21], [22], [23], [24], [25], [26], [27], [28], [7]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[2], [3], [4], [66]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[2], [3], [4], [67]
D0535		Droperidol	C22H22FN3O2	3168	Major		Inter Info	[2], [3], [4], [68], [69], [7]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[2], [75], [3], [4], [76], [77], [7]
D0712		Gatifloxacin	C19H22FN3O4	5379	Major		Inter Info	[79], [80], [81], [2], [3], [4], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101]
D0740		Grepafloxacin	C19H22FN3O3	72474	Major		Inter Info	[80], [2], [3], [4], [102], [103], [104]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[105], [2], [3], [4], [106], [107], [108], [109], [110]
D0750		Haloperidol	C21H23ClFNO2	3559	Major		Inter Info	[2], [3], [4], [111], [112], [113], [114], [115], [116], [7]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Major		Inter Info	[43], [4], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[2], [3], [4], [117]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[2], [3], [4], [118], [7]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[119]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[4], [122], [7]
D0960		Lumefantrine	C30H32Cl3NO	6437380	Major		Inter Info	[3], [4], [124]
D0965		Macimorelin	C26H30N6O3	9804938	Major		Inter Info	[125]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[2], [3], [4], [126], [7]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[2], [3], [4], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [7]
D1136		Nilotinib	C28H22F3N7O	644241	Major		Inter Info	[2], [3], [4], [137]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[139]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[141]
D1223		Papaverine	C20H21NO4	4680	Major		Inter Info	[142], [143], [144], [145], [146], [147], [148], [149]
D1230		Pasireotide	C58H66N10O9	9941444	Major		Inter Info	[2], [3], [4], [150]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[4], [68], [151], [7]
D1343		Procainamide	C13H21N3O	4913	Major		Inter Info	[2], [3], [4], [20], [21], [22], [23], [24], [25], [26], [27], [28], [7]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[2], [3], [4], [20], [21], [22], [23], [24], [25], [26], [27], [28], [7]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[4], [156]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[2], [3], [4], [20], [21], [22], [23], [24], [25], [26], [27], [28], [7]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Major		Inter Info	[80], [2], [3], [4], [158], [159], [84], [86], [88], [160], [89], [90], [161], [92], [93], [94], [95], [162], [99], [104], [163]
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[2], [3], [4], [198], [68], [199], [200], [201], [7]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[2], [3], [4], [202]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[2], [3], [4], [203]
D1726		Ziprasidone	C21H21ClN4OS	60854	Major		Inter Info	[2], [3], [4], [68], [205], [7]
D0003		Abarelix	C72H95ClN14O14	16131215	Moderate		Inter Info	[4], [206], [207], [208], [209], [210], [211], [212]
D0139		Azithromycin	C38H72N2O12	447043	Moderate		Inter Info	[65], [1]
D0737		Goserelin	C59H84N18O14	5311128	Moderate		Inter Info	[4], [206], [207], [208], [209], [210], [211], [212]
D0908		Leuprolide	C59H84N16O12	657181	Moderate		Inter Info	[4], [206], [207], [208], [209], [210], [211], [212]
D1210		Oxytocin	C43H66N12O12S2	439302	Moderate		Inter Info	[65], [1]
D0007		Abiraterone	C24H31NO	132971	Moderate		Inter Info	[4], [206], [207], [208], [209], [210], [211], [212]
D0036		Alfuzosin	C19H27N5O4	2092	Moderate		Inter Info	[65], [1]
D0037		Alimemazine	C18H22N2S	5574	Moderate		Inter Info	[65], [1]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[65], [1]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[65], [1]
D0097		Apomorphine	C17H17NO2	6005	Moderate		Inter Info	[65], [1]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[2], [3], [4], [271], [7]
D0115		Astemizole	C28H31FN4O	2247	Moderate		Inter Info	[65], [1]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[2], [3], [4], [298], [65], [299], [300], [301], [302], [1], [303], [304]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[65], [1]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[65], [1]
D0358		Clofazimine	C27H22Cl2N4	2794	Moderate		Inter Info	[367]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[65], [1]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[65], [1]
D0437		Degarelix	C82H103ClN18O16	16136245	Moderate		Inter Info	[4], [206], [207], [208], [209], [210], [211], [212]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[65], [1]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[65], [1]
D0526		Doxepin (topical)	C19H21NO	667477	Moderate		Inter Info	[65], [1]
D0528		Doxorubicin	C27H29NO11	31703	Moderate		Inter Info	[65], [1]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Moderate		Inter Info	[65], [1]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[423]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[3], [4], [424]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[65], [1]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[2], [3], [4], [426]
D0632		Ezogabine	C16H18FN3O2	121892	Moderate		Inter Info	[65], [1]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[3], [4], [428]
D0664		Flecainide	C17H20F6N2O3	3356	Moderate		Inter Info	[65], [1]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[65], [1]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[65], [1]
D0682		Flutamide	C11H11F3N2O3	3397	Moderate		Inter Info	[4], [206], [207], [208], [209], [210], [211], [212]
D0694		Foscarnet	CH3O5P	3415	Moderate		Inter Info	[65], [1]
D0700		Fostemsavir	C25H26N7O8P	11319217	Moderate		Inter Info	[65], [1]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[65], [1]
D0738		Granisetron	C18H24N4O	5284566	Moderate		Inter Info	[65], [1]
D0751		Halothane	C2HBrClF3	3562	Moderate		Inter Info	[65], [1]
D0758		Histrelin	C66H86N18O12	25077993	Moderate		Inter Info	[4], [206], [207], [208], [209], [210], [211], [212]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[65], [1]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[65], [1]
D0806		Inotuzumab ozogamicin	NA	NA	Moderate		Inter Info	[65], [1]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Moderate		Inter Info	[65], [1]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[65], [1]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Moderate		Inter Info	[4]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[65], [1]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Moderate		Inter Info	[65], [1]
D0947		Loperamide	C29H33ClN2O2	3955	Moderate		Inter Info	[444], [445]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[65], [1]
D0992		Mefloquine	C17H16F6N2O	4046	Moderate		Inter Info	[65], [1]
D1026		Methotrimeprazine	C19H24N2OS	72287	Moderate		Inter Info	[65], [1]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[65], [1]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[452]
D1137		Nilutamide	C12H10F3N3O4	4493	Moderate		Inter Info	[4], [206], [207], [208], [209], [210], [211], [212]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[65], [1]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[65], [1]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[65], [1]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[3], [4], [458]
D1181		Ondansetron	C18H19N3O	4595	Moderate		Inter Info	[65], [1]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[65], [1]
D1211		Ozanimod	C23H24N4O3	52938427	Moderate		Inter Info	[65], [1]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[65], [1]
D1216		Palonosetron	C19H24N2O	6337614	Moderate		Inter Info	[65], [1]
D1232		Pazopanib	C21H23N7O2S	10113978	Moderate		Inter Info	[65], [1]
D1246		Pentamidine	C19H24N4O2	4735	Moderate		Inter Info	[65], [1]
D1254		Perflutren	C3F8	6432	Moderate		Inter Info	[463], [464]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[65], [1]
D1290		Pimavanserin	C25H34FN3O2	10071196	Moderate		Inter Info	[467]
D1339		Primaquine	C15H21N3O	4908	Moderate		Inter Info	[65], [1]
D1342		Probucol	C31H48O2S2	4912	Moderate		Inter Info	[65], [1]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[65], [1]
D1351		Promazine	C17H20N2S	4926	Moderate		Inter Info	[65], [1]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[65], [1]
D1353		Propafenone	C21H27NO3	4932	Moderate		Inter Info	[65], [1]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[472], [473], [474], [475], [476], [477], [478], [479], [480], [481]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[65], [1]
D1372		Quinine	C20H24N2O2	3034034	Moderate		Inter Info	[65], [1]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[65], [1]
D1413		Risperidone	C23H27FN4O2	5073	Moderate		Inter Info	[65], [1]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[65], [1]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[65], [1]
D1491		Solifenacin	C23H26N2O2	154059	Moderate		Inter Info	[65], [1]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Moderate		Inter Info	[2], [3], [4], [494]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[65], [1]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Moderate		Inter Info	[65], [1]
D1555		Terfenadine	C32H41NO2	5405	Moderate		Inter Info	[65], [1]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[65], [1]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[509], [510], [511], [512], [513], [514], [7]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Moderate		Inter Info	[65], [1]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[65], [1]
D1638		Triflupromazine	C18H19F3N2S	5568	Moderate		Inter Info	[65], [1]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[65], [1]
D1651		Triptorelin	C64H82N18O13	25074470	Moderate		Inter Info	[4], [206], [207], [208], [209], [210], [211], [212]
D1682		Vardenafil	C23H32N6O4S	135400189	Moderate		Inter Info	[65], [1]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[65], [1]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[65], [1]
D1051		Metronidazole	C6H9N3O3	4173	Minor		Inter Info	[3], [527], [528], [529]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[2], [3], [4], [540], [541], [542], [543]
	Increased risk of ventricular arrhythmias					Drug Num: 35
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0107		Arsenic trioxide	As2O3	14888	Major		Inter Info	[31], [32]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[2], [3], [4], [78], [8]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[3], [157]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243]
D0025		Adenosine	C10H13N5O4	60961	Moderate		Inter Info	[2], [247], [3], [4], [248], [249], [250], [62], [251], [252]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243]
D0184		Bisacodyl	C22H19NO4	2391	Moderate		Inter Info	[2], [3], [4], [277], [278], [279]
D0269		Castor oil	C57H104O9	14030006	Moderate		Inter Info	[2], [3], [4], [277], [278], [279]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243]
D0701		Frangula purshiana bark	NA	NA	Moderate		Inter Info	[3], [4], [279]
D0731		Glycerin	C3H8O3	753	Moderate		Inter Info	[2], [3], [4], [277], [278], [279]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[227], [237], [240]
D0887		Lactitol	C12H24O11	157355	Moderate		Inter Info	[2], [3], [4], [277], [278], [279]
D0888		Lactulose	C12H22O11	11333	Moderate		Inter Info	[2], [3], [4], [277], [278], [279]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[227], [237], [240]
D0970		Magnesium citrate	C12H10Mg3O14	6099959	Moderate		Inter Info	[2], [3], [4], [277], [278], [279]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[2], [3], [4], [277], [278], [279]
D1069		Mineral oil	NA	NA	Moderate		Inter Info	[2], [3], [4], [277], [278], [279]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[227], [237], [240]
D1266		Phenolphthalein	C20H14O4	4764	Moderate		Inter Info	[2], [3], [4], [277], [278], [279]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[4], [465], [466]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[4], [465], [466]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[3], [4], [279]
D1414		Ritodrine	C17H21NO3	33572	Moderate		Inter Info	[214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243]
D1418		Rivastigmine	C14H22N2O2	77991	Moderate		Inter Info	[2], [3], [4], [486], [487], [488]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[227], [237], [240]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[4], [465], [466]
D1525		Tacrine	C13H14N2	1935	Moderate		Inter Info	[2], [3], [4], [486], [487], [488]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[3], [4], [502]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[227], [237], [240]
Pharmacodynamic antagonistic effects
	Attenuated pharmacological effects (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1905		Tetrofosmin	C18H40O4P2	4274	Moderate		Inter Info	[501]

References
1	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
2	Canadian Pharmacists Association.
3	Cerner Multum, Inc. "Australian Product Information.".
4	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
5	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
6	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
7	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
8	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
9	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
10	Product Information. Sporanox (itraconazole). Janssen Pharmaceutica, Titusville, NJ.
11	Holtzman CW, Wiggins BS, Spinler SA "Role of P-glycoprotein in statin drug interactions." Pharmacotherapy 26 (2006): 1601-7. [PMID: 17064205]
12	Hylton AC, Ezekiel TO "Rhabdomyolysis in a patient receiving ranolazine and simvastatin." Am J Health Syst Pharm 67 (2010): 1829-31. [PMID: 20966146]
13	Neuvonen PJ, Backman JT, Niemi M "Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin." Clin Pharmacokinet 47 (2008): 463-74. [PMID: 18563955]
14	Product Information. Mevacor (lovastatin). Merck & Co, Inc, West Point, PA.
15	Product Information. Zocor (simvastatin). Merck & Co, Inc, West Point, PA.
16	Rifkin SI "Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report." Medscape J Med 10 (2008): 264. [PMID: 19099014]
17	Thompson PD, Clarkson P, Karas RH "Statin-associated myopathy." JAMA 289 (2003): 1681-90. [PMID: 12672737]
18	Worz CR, Bottorff M "The role of cytochrome P450-mediated drug-drug interactions in determining the safety of statins." Expert Opin Pharmacother 2 (2001): 1119-27. [PMID: 11583063]
19	Jerling M, Huan BL, Leung K, Chu N, Abdallah H, Hussein Z "Studies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in healthy subjects." J Clin Pharmacol 45 (2005): 422-33. [PMID: 15778423]
20	Maxa JL, Hebeler RF, Adeeko MA "Torsades de pointes following concurrent amiodarone and levofloxacin therapy." Proc (Bayl Univ Med Cent) 19 (2006): 345-6. [PMID: 17106497]
21	Product Information. Betapace (sotalol). Berlex, Richmond, CA.
22	Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
23	Product Information. Norpace (disopyramide). Searle, Skokie, IL.
24	Product Information. Procan SR (procainamide). Parke-Davis, Morris Plains, NJ.
25	Product Information. Quiniglute (quinidine). Berlex, Richmond, CA.
26	Product Information. Vascor (bepridil). McNeil Pharmaceutical, Raritan, NJ.
27	Trujillo TC, Nolan PE "Antiarrhythmic agents - Drug interactions of clinical significance." Drug Safety 23 (2000): 509-32. [PMID: 11144659]
28	Yamreudeewong W, DeBisschop M, Martin L, Lower D "Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs." Drug Saf 26 (2003): 421-38. [PMID: 12688833]
29	Product Information. Barhemsys (amisulpride). Acacia Pharma, Inc, Indianapolis, IN.
30	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
31	Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
32	Product Information. Trisenox (arsenic trioxide) Cephalon Inc, West Chester, PA.
33	Correa D, Landau M "Ranolazine-induced myopathy in a patient on chronic statin therapy." J Clin Neuromuscul Dis 14 (2013): 114-6. [PMID: 23492463]
34	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
35	Hutchinson MR, Menelaou A, Foster DJ, Coller JK, Somogyi AA "CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes." Br J Clin Pharmacol 57 (2004): 287-97. [PMID: 14998425]
36	Product Information. Zohydro ER (HYDROcodone). Zogenix, Inc, San Diego, CA.
37	Vizcaychipi MP, Walker S, Palazzo M "Serotonin syndrome triggered by tramadol." Br J Anaesth 99 (2007): 919. [PMID: 18006535]
38	Product Information. Orladeyo (berotralstat). BioCryst Pharmaceuticals Inc, Durham, NC.
39	Bailey DG, Dresser GK "Natural products and adverse drug interactions." Can Med Assoc J 170 (2004): 1531-2. [PMID: 15136542]
40	Ho PC, Ghose K, Saville D, Wanwimolruk S "Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers." Eur J Clin Pharmacol 56 (2000): 693-8. [PMID: 11214778]
41	Product Information. Bevyxxa (betrixaban). Portola Pharmaceuticals, South San Francisco, CA.
42	Product Information. Rexulti (brexpiprazole). Otsuka American Pharmaceuticals Inc, Rockville, MD.
43	Harper KM, Knapp DJ, Criswell HE, Breese GR "Vasopressin and alcohol: A multifaceted relationship." Psychopharmacology (Berl) 235 (2018): 3363-79. [PMID: 32936259]
44	Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C "COVID-19 and (hydroxy)chloroquine-azithromycin combination: should we take the risk for our patients?" Br J Clin Pharmacol Apr 29 (2020): epub ahead of print. [PMID: 32350872]
45	National Institutes of Health (NIH) "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.".
46	Product Information. Chloroquine Phosphate (chloroquine). West-Ward Pharmaceutical Corporation, Eatontown, NJ.
47	Product Information. Hydroxychloroquine Sulfate (hydroxychloroquine). Prasco Laboratories, Cincinnati, OH.
48	Product Information. Plaquenil (R). (hydroxychloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
49	Roden DM, Harrington RA, Poppas A, Russo AM "Considerations for drug interactions on QTc in exploratory COVID-19 (Coroanvirus disease 2019) treatment." Heart Rhythm Apr 14 (2020): epub ahead of print. [PMID: 32302703]
50	Sacher F, Fauchier L, Boveda S, et.al "Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection." Arch Cardiovasc Dis Apr 24 (2020): epub ahead of print. [PMID: 32354666]
51	Saleh M, Gabriels J, ChangD, et.al "The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection." Circ Arrhythm Electrophysiol Apr 29 (2020): epub ahead of print. [PMID: 32347743]
52	Sapp JL, Alqarawi W, MacIntyre CJ, et.al "Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: A statement from the Canadian Heart Rhythm Society." Can J Cardiol Apr 8 (2020): epub ahead of print. [PMID: 32299753]
53	Smit C, Peeters MYM, van den Anker JN, Knibbe CAJ "Chloroquine for SARS-CoV-2: Implications of its unique pharmacokinetic and safety properties." Clin Pharmacokinet Ar 18 (2020): epub ahead of print. [PMID: 32306288]
54	Bessiere F, Roccia H, Deliniere A, et.al "Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit." JAMA Cardiol May 1 (2020): epub ahead of print. [PMID: 32936266]
55	Borba MGS, Val FFA, Sampaio VS, et.al "Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 1 (SARS-CoV-2) infection: A randomized clinical trial." JAMA Netw Open Apr 1 (2020): epub ahead of print. [PMID: 32330277]
56	Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ "Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)" Mayo Clin Proc Apr 7 (2020): epub ahead of print. [PMID: 32359771]
57	Kapoor A, Pandurangi U, Arora V, et.al "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society." Indian Pacing Electorphysiol J Apr 8 (2020): epub ahead of print. [PMID: 32278018]
58	Mercuro NJ, Yen CF, Shim DJ, et.al "Risk of QT interval prolongation associated with the use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)" JAMA Cardiol May 1:e201834 (2020): epub ahead of print. [PMID: 32936252]
59	mitra RL, Greenstein SA, Epstein lm "An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin Possible benefits of intravenous lidocaine." HeartRythm Case Rep Apr 1 (2020): epub ahead of print. [PMID: 32363145]
60	US Food and Drug Administration "FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF CHLOROQUINE PHOSPHATE SUPPLIED FROM THE STRATEGIC NATIONAL STOCKPILE FOR TREATMENT OF COVID-19 IN CERTAIN HOSPITALIZED PATIENTS. Available from: URL: https://www.fda.gov/media/13653" ([2020, Apr 27]):.
61	US Food and Drug Administration "Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems.".
62	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
63	Product Information. Propulsid (cisapride). Janssen Pharmaceutica, Titusville, NJ.
64	Trinkle R "Comment: syncopal episodes associated with cisapride." Ann Pharmacother 33 (1999): 251. [PMID: 10084425]
65	European Medicines Agency "CHMP Assessment Report for Latixa. International nonproprietary name: ranolazine.".
66	Product Information. Anzemet (dolasetron). Hoechst Marion-Roussel Inc, Kansas City, MO.
67	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
68	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
69	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
70	Mendell J, Zahir H, Matsushima N, et al. "Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor." Am J Cardiovasc Drugs (2013):. [PMID: 23784266]
71	Parasrampuria DA, Mendell J, Shi M, Matsushima N, Zahir H, Truitt K "Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine." Br J Clin Pharmacol 0 (2016): epub. [PMID: 27530188]
72	Product Information. Savaysa (edoxaban). Daiichi Sankyo, Inc., Parsippany, NJ.
73	Product Information. Cerdelga (eliglustat). Genzyme Corporation, Cambridge, MA.
74	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
75	Castro VM, Clements CC, Murphy SN, et al. "QT interval and antidepressant use: a cross sectional study of electronic health records." BMJ 346 (2013): f288. [PMID: 23360890]
76	Do A, Noohi S, Elie D, et al. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.?Psychosomatics. 2016;57(1):57-63. [PMID: 26633294]
77	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
78	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
79	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
80	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
81	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
82	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
83	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
84	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
85	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
86	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
87	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
88	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
89	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
90	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
91	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
92	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
93	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
94	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
95	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
96	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
97	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
98	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
99	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
100	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
101	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
102	Lode H, Vogel F, Elies W "Grepafloxacin: A review of its safety profile based on clinical trials and postmarketing surveillance." Clin Ther 21 (1999): 61-74. [PMID: 10090425]
103	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
104	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
105	Abernethy DR, Wesche DL, Barbey JT, et al. "Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation." Br J Clin Pharmacol 51 (2001): 231-7. [PMID: 11298069]
106	Giao PT, de Vries PJ "Pharmacokinetic interactions of antimalarial agents." Clin Pharmacokinet 40 (2001): 343-73. [PMID: 11432537]
107	Nosten F, ter Kuile FO, Luxemburger C, et al "Cardiac effects of antimalarial treatment with halofantrine." Lancet 341 (1993): 1054-6. [PMID: 8096959]
108	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
109	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
110	Sudden death in a traveler following halofantrine administration--Togo, 2000. MMWR Morb Mortal Wkly Rep 50 (2001): 169-70, 179. [PMID: 11393488]
111	Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, Yonezawa Y "The association between intravenous haloperidol and prolonged QT interval." J Clin Psychopharmacol 21 (2001): 257-61. [PMID: 11386487]
112	Huyse F, van Schijndel RS "Haloperidol and cardiac arrest." Lancet 2 (1988): 568-9. [PMID: 2900948]
113	Metzger E, Friedman R "Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill." J Clin Psychopharmacol 13 (1993): 128-32. [PMID: 8463445]
114	O'Brien JM, Rockwood RP, Suh KI "Haloperidol-induced torsade de pointes." Ann Pharmacother 33 (1999): 1046-9. [PMID: 10534216]
115	Product Information. Haldol (haloperidol). McNeil Pharmaceutical, Raritan, NJ.
116	Wilt JL, Minnema AM, Johnson RF, Rosenblum AM "Torsade de pointes associated with the use of intravenous haloperidol." Ann Intern Med 119 (1993): 391-4. [PMID: 8338292]
117	Product Information. Corvert (ibutilide). Pharmacia and Upjohn, Kalamazoo, MI.
118	Product Information. Exforge HCT (amlodipine/hydrochlorothiazide/valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
119	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
120	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
121	Product Information. Dayvigo (lemborexant). Eisai Inc, Woodcliff Lake, NJ.
122	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
123	Product Information. Diabinese (chlorpropamide). Pfizer US Pharmaceuticals, New York, NY.
124	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
125	Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
126	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
127	De Bels D, Staroukine M, Devriendt J "Torsades de pointes due to methadone." Ann Intern Med 139 (2003): E156. [PMID: 12859181]
128	Ehret GB, Desmeules JA, Broers B "Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology." Expert Opin Drug Saf 6 (2007): 289-303. [PMID: 17480178]
129	Gil M, Sala M, Anguera I, et al. "QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone." Am J Cardiol 92 (2003): 995-7. [PMID: 14556883]
130	Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS "Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes." Pharmacotherapy 23 (2003): 802-5. [PMID: 12820821]
131	Krantz MJ, Lewkowiez L, Hays H, et al "Torsade de pointes associated with very-high-dose methadone." Ann Intern Med 137 (2002): 501-4. [PMID: 12230351]
132	Krantz MJ, Mehler PS "Synthetic opioids and QT prolongation." Arch Intern Med 163 (2003): 1615 author reply 1615. [PMID: 12860589]
133	Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN "Impact of methadone treatment on cardiac repolarization and conduction in opioid users." Am J Cardiol 95 (2005): 915-8. [PMID: 15781034]
134	Mokwe EO, Ositadinma O "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966000]
135	Sala M, Anguera I, Cervantes M "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966001]
136	Walker PW, Klein D, Kasza L "High dose methadone and ventricular arrhythmias: a report of three cases." Pain 103 (2003): 321-4. [PMID: 12791438]
137	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
138	Product Information. Olinvyk (oliceridine). Trevena Inc, Chesterbrook, PA.
139	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
140	Product Information. OxyContin (oxycodone). Purdue Frederick Company, Norwalk, CT.
141	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
142	Goto M, Sato M, Kitzazawa H, et.al "Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation." Intern Med 53 (2014): 1629-31. [PMID: 25088875]
143	Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y "QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine." Cardiology 84 (1994): 9-13. [PMID: 7511988]
144	Jain A, Jenkins MG "Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine." Cathet Cardiovasc Diagn 18 (1989): 255-7. [PMID: 2605630]
145	Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T "Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve." Cathet Cardiovasc Diagn 19 (1990): 229-36. [PMID: 2334953]
146	Nakayama M, Saito A, Kitazawa H, et.al "Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases." Intern Med 51 (2012): 351-6. [PMID: 22333368]
147	Nakayama M, Tanaka N, Sakoda K, et.al "Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease." Circ J 79 (2015): 530-6. [PMID: 25746536]
148	Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML "Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine." J Am Coll Cardiol 15 (1990): 275-8. [PMID: 2299067]
149	Vrolix M, Piessens J, De Geest H "Torsades de pointes after intracoronary papaverine." Eur Heart J 12 (1991): 273-6. [PMID: 2044564]
150	Product Information. Signifor (pasireotide). Novartis Pharmaceuticals, East Hanover, NJ.
151	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
152	Product Information. Orgovyx (relugolix). Myovant Sciences, Inc., Brisbane, CA.
153	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
154	Product Information. Uroxatral (alfuzosin). sanofi-aventis , Bridgewater, NJ.
155	Abbas R, Hug BA, Leister C, Sonnichsen D "A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects." Int J Cancer 131 (2012): Epub. [PMID: 22065400]
156	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
157	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
158	Demolis JL, Charransol A, Funck-Brentano C, Jaillon P "Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers." Br J Clin Pharmacol 41 (1996): 499-503. [PMID: 8799513]
159	Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B "Torsades de pointe probably related to sparfloxacin." Eur J Clin Microbiol Infect Dis 15 (1996): 350-1. [PMID: 8781892]
160	Jaillon P, Morganroth J, Brumpt I, Talbot G "Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group." J Antimicrob Chemother 37(suppl a) (1996): 161-7. [PMID: 8737135]
161	Lipsky BA, Dorr MB, Magner DJ, Talbot GH "Safety profile of sparfloxacin, a new fluoroquinolone antibiotic." Clin Ther 21 (1999): 148-59. [PMID: 10090432]
162	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
163	Zix JA, GeerdesFenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
164	Amchin J, Ereshefsky L, Zarycranski W, Taylor K, Albano D, Klockowski PM "Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe." J Clin Pharmacol 41 (2001): 443-51. [PMID: 11304901]
165	Aubert RE, Stanek EJ, Yao J, et al "Increased risk of breast cancer recurrence in women initiating tamoxifen with CYP2D6 inhibitors".
166	Bonanni B, Macis D, Maisonneuve P, et al. "Polymorphism in the CYP2D6 tamoxifen-metabolizing gene influences clinical effect but not hot flashes: data from the Italian Tamoxifen Trial." J Clin Oncol 24 (2006): 3708-9. [PMID: 16877740]
167	Borges S, Desta Z, Li L, et al. "Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment." Clin Pharmacol Ther 80 (2006): 61-74. [PMID: 16815318]
168	Borgna JL, Rochefort H "Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues." J Biol Chem 256 (1981): 859-68. [PMID: 7451477]
169	Brauch H, Murdter TE, Eichelbaum M, Schwab M "Pharmacogenomics of tamoxifen therapy." Clin Chem 55 (2009): 1770-82. [PMID: 19574470]
170	Coller JK, Krebsfaenger N, Klein K, et al. "The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver." Br J Clin Pharmacol 54 (2002): 157-167. [PMID: 12207635]
171	Crewe HK, Lennard MS, Tucker GT, Woods FR, Haddock RE "The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes." Br J Clin Pharmacol 34 (1992): 262-5. [PMID: 1389951]
172	Dehal SS, Kupfer D "CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver." Cancer Res 57 (1997): 3402-6. [PMID: 9270005]
173	Desta Z, Flockhart DA "Germline pharmacogenetics of tamoxifen response: have we learned enough?" J Clin Oncol 25 (2007): 5147-9. [PMID: 18024859]
174	Desta Z, Ward BA, Soukhova NV, Flockhart DA "Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6." J Pharmacol Exp Ther (2004):. [PMID: 15159443]
175	Dezentje VO, Guchelaar HJ, Nortier JW, van de Velde CJ, Gelderblom H "Clinical implications of CYP2D6 genotyping in tamoxifen treatment for breast cancer." Clin Cancer Res 15 (2009): 15-21. [PMID: 19118028]
176	Gaston C, Kolesar J "Clinical Significance of CYP2D6 Polymorphisms and Tamoxifen in Women with Breast Cancer." Clin Adv Hematol Oncol 6 (2008): 825-33. [PMID: 19194367]
177	Goetz MP, Kamal A, Ames MM "Tamoxifen Pharmacogenomics: The Role of CYP2D6 as a Predictor of Drug Response." Clin Pharmacol Ther (2007):. [PMID: 17882159]
178	Goetz MP, Loprinzi CL "A hot flash on tamoxifen metabolism." J Natl Cancer Inst 95 (2003): 1734-5. [PMID: 14652227]
179	Goetz MP, Rae JM, Suman VJ, et al. "Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes." J Clin Oncol 23 (2005): 9312-8. [PMID: 16361630]
180	Henry NL, Stearns V, Flockhart DA, Hayes DF, Riba M "Drug interactions and pharmacogenomics in the treatment of breast cancer and depression." Am J Psychiatry 165 (2008): 1251-5. [PMID: 18829880]
181	Jin Y, Desta Z, Stearns V, et al. "CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment." J Natl Cancer Inst 97 (2005): 30-9. [PMID: 15632378]
182	Johnson MD, Zuo H, Lee KH, et al. "Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen." Breast Cancer Res Treat 85 (2004): 151-9. [PMID: 15111773]
183	Jordan VC "Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance." Breast Cancer Res Treat 2 (1982): 123-38. [PMID: 6184101]
184	Jordan VC, Collins MM, Rowsby L, Prestwich G "A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity." J Endocrinol 75 (1977): 305-16. [PMID: 591813]
185	Lash TL, Pedersen L, Cronin-Fenton D, et al "Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram." Br J Cancer 99 (2008): 616-21. [PMID: 20385012]
186	Lehmann D, Nelsen J, Ramanath V, Newman N, Duggan D, Smith A "Lack of attenuation in the antitumor effect of tamoxifen by chronic CYP isoform inhibition." J Clin Pharmacol 44 (2004): 861-5. [PMID: 15286089]
187	Lim HS, Ju Lee H, Seok Lee K, Sook Lee E, Jang IJ, Ro J "Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer." J Clin Oncol 25 (2007): 3837-45. [PMID: 17761971]
188	McCaffrey P "Genetics and drug interactions affect tamoxifen metabolism." Lancet Oncol 6 (2005): 72. [PMID: 15704296]
189	Ponzone R, Biglia N, Sismondi P "Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine." J Natl Cancer Inst 96 (2004): 883-4 author reply 884-5. [PMID: 15173274]
190	Rochat B "Role of cytochrome p450 activity in the fate of anticancer agents and in drug resistance : focus on tamoxifen, Paclitaxel and imatinib metabolism." Clin Pharmacokinet 44 (2005): 349-66. [PMID: 15828850]
191	Schroth W, Antoniadou L, Fritz P, et al. "Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes." J Clin Oncol 25 (2007): 5187-93. [PMID: 18024866]
192	Stearns V, Johnson MD, Rae JM, et al. "Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine." J Natl Cancer Inst 95 (2003): 1758-64. [PMID: 14652237]
193	Wegman P, Elingarami S, Carstensen J, Stal O, Nordenskjold B, Wingren S "Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer." Breast Cancer Res 9 (2007): R7. [PMID: 17244352]
194	Wegman P, Vainikka L, Stal O, et al "Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients." Breast Cancer Res 7 (2005): R284-90. [PMID: 15987423]
195	Young D "Genetics examined in tamoxifen's effectiveness: recurrence warning urged for labeling." Am J Health Syst Pharm 63 (2006): 2286, 2296. [PMID: 17105997]
196	Crewe HK, Notley LM, Wunsch RM, Lennard MS, Gillam EM "Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen." Drug Metab Dispos 30 (2002): 869-74. [PMID: 12124303]
197	Ratliff B, Dietze EC, Bean GR, Moore C, Wanko S, Seewaldt VL "Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine." J Natl Cancer Inst 96 (2004): 883 author reply 884-5. [PMID: 15173275]
198	Fletcher GF, Kazamias TM "Cardiotoxic effects of Mellaril: conduction disturbances and supraventricular arrhythmias." Am Heart J 78 (1969): 135-8. [PMID: 5794785]
199	Hartigan-Go K, Bateman DN, Nyberg G, Martensson E, Thomas SHL "Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans." Clin Pharmacol Ther 60 (1996): 543-53. [PMID: 8941027]
200	Liberatore MA, Robinson DS "Torsade de pointes: a mechanism for sudden death associated with neuroleptic drug therapy?" J Clin Psychopharmacol 4 (1984): 143-6. [PMID: 6145728]
201	Product Information. Mellaril (thioridazine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
202	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
203	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
204	Product Information. Venclexta (venetoclax). AbbVie US LLC, North Chicago, IL.
205	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
206	Product Information. Eligard (leuprolide). Sanofi Winthrop Pharmaceuticals, New York, NY.
207	Product Information. Firmagon (degarelix). Ferring Pharmaceuticals Inc, Tarrytown, NY.
208	Product Information. Lupron (leuprolide). TAP Pharmaceuticals Inc, Deerfield, IL.
209	Product Information. Plenaxis (abarelix). Praecis Pharmaceuticals Inc, Waltham, MA.
210	Product Information. Trelstar (triptorelin) Pharmacia and Upjohn, Kalamazoo, MI.
211	Product Information. Vantas (histrelin). Endo Pharmaceuticals (formally Indevus Pharmaceuticals Inc), Lexington, MA.
212	Product Information. Zoladex (goserelin). Zeneca Pharmaceuticals, Wilmington, DE.
213	Product Information. Evoxac (cevimeline) Daiichi Pharmaceuticals, Fort lee, NJ.
214	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
215	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
216	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
217	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
218	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
219	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
220	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
221	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
222	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
223	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
224	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
225	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
226	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
227	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
228	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
229	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
230	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
231	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
232	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
233	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
234	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
235	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
236	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
237	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
238	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
239	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
240	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
241	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
242	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
243	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
244	Product Information. Verzenio (abemaciclib). Lilly, Eli and Company, Indianapolis, IN.
245	Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
246	Product Information. Qelbree (viloxazine). Supernus Pharmaceuticals Inc, Rockville, MD.
247	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
248	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
249	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
250	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
251	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
252	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
253	Bartkowski RR, Goldberg ME, Larijani GE, Boerner T "Inhibition of alfentanil metabolism by erythromycin." Clin Pharmacol Ther 46 (1989): 99-102. [PMID: 2501060]
254	Bartkowski RR, McDonnell TE "Prolonged alfentanil effect following erythromycin administration." Anesthesiology 73 (1990): 566-8. [PMID: 2203286]
255	Kharasch ED, Thummel KE "Human alfentanil metabolism by cytochrome P450 3A3/4. An explanation for the interindividual variability in alfentanil clearance?" Anesth Analg 76 (1993): 1033-9. [PMID: 8484504]
256	Kharasch ED, Walker A, Hoffer C, Sheffels P "Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis." Clin Pharmacol Ther 76 (2004): 452-66. [PMID: 15536460]
257	Klees TM, Sheffels P, Dale O, Kharasch ED "Metabolism of alfentanil by cytochrome P4503A enzymes." Drug Metab Dispos 33 (2005): 303-11. [PMID: 15557344]
258	Klees TM, Sheffels P, Thummel KE, Kharasch ED "Pharmacogenetic Determinants of Human Liver Microsomal Alfentanil Metabolism and the Role of Cytochrome P450 3A5." Anesthesiology 102 (2005): 550-556. [PMID: 15731592]
259	Koehntop DE, Noormohamed SE, Fletcher CV "Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation." Pharmacotherapy 14 (1994): 592-9. [PMID: 7997393]
260	Labroo RB, Thummel KE, Kunze KL, Podoll T, Trager WF, Kharasch ED "Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism." Drug Metab Dispos 23 (1995): 490-6. [PMID: 7600917]
261	Palkama VJ, Isohanni MH, Neuvonen PJ, Olkkola KT "The effect of intravenous and oral fluconazole on the pharmacokinetics and pharmacodynamics of intravenous alfentanil." Anesth Analg 87 (1998): 190-4. [PMID: 9661572]
262	Product Information. Alfenta (alfentanil). Janssen Pharmaceutica, Titusville, NJ.
263	Yate PM, Thomas D, Short SM, Sebel PS, Morton J "Comparison of infusions of alfentanil or pethidine for sedation of ventilated patients on the ITU." Br J Anaesth 58 (1986): 1091-9. [PMID: 2876719]
264	Yun CH, Wood M, Wood AJ, Guengerich FP "Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4: an explanation of the variable elimination clearance." Anesthesiology 77 (1992): 467-74. [PMID: 1519785]
265	Ibrahim AE, Feldman J, Karim A, Kharasch ED "Simultaneous Assessment of Drug Interactions with Low- and High-Extraction Opioids: Application to Parecoxib Effects on the Pharmacokinetics and Pharmacodynamics of Fentanyl and Alfentanil." Anesthesiology 98 (2003): 853-861. [PMID: 12657846]
266	Kharasch ED, Russell M, Mautz D, Thummel KE, Kunze KL, Bowdle A, Cox K "The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions." Anesthesiology 87 (1997): 36-50. [PMID: 9232132]
267	Product Information. Tekturna (aliskiren). Novartis Pharmaceuticals, East Hanover, NJ.
268	Tapaninen T, Backman JT, Kurkinen K, Neuvonen P, Niemi M "Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren." J Clin Pharmacol 51 (2011): 359-67. [PMID: 20400651]
269	Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
270	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
271	Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
272	Belle DJ, Ernest CS, Sauer JM, Smith BP, Thomasson HR, Witcher JW "Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics." J Clin Pharmacol 42 (2002): 1219-27. [PMID: 12412820]
273	Product Information. Strattera (atomoxetine). Lilly, Eli and Company, Indianapolis, IN.
274	Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
275	Product Information. Inlyta (axitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
276	Product Information. Mektovi (binimetinib). Array BioPharma Inc., Boulder, CO.
277	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
278	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
279	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
280	Product Information. Bosulif (bosutinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
281	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
282	Product Information. Mavyret (glecaprevir-pibrentasvir). Abbott Pharmaceutical, Abbott Park, IL.
283	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
284	Bolland MJ, Bagg W, Thomas MG, Lucas JA, Ticehurst R, Black PN "Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole." Ann Pharmacother 38 (2004): 46-9. [PMID: 14742792]
285	Daveluy A, Raignoux C, Miremont-Salame G, et al. "Drug interactions between inhaled corticosteroids and enzymatic inhibitors." Eur J Clin Pharmacol (2009):. [PMID: 19399485]
286	De Wachter E, Malfroot A, De Schutter I, Vanbesien J, De Schepper J "Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450." J Calif Dent Assoc 2 (2003): 72-5. [PMID: 15463853]
287	De Wachter E, Vanbesien J, De Schutter I, Malfroot A, De Schepper J "Rapidly developing Cushing syndrome in a 4-year-old patient during combined treatment with itraconazole and inhaled budesonide." Eur J Pediatr (2003):. [PMID: 12719971]
288	Edsbacker S, Andersson T "Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease." Clin Pharmacokinet 43 (2004): 803-21. [PMID: 15355126]
289	Jonsson G, Astrom A, Andersson P "Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver." Drug Metab Dispos 23 (1995): 137-42. [PMID: 7720517]
290	Kedem E, Shahar E, Hassoun G, Pollack S "Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient." J Asthma 47 (2010): 830-1. [PMID: 20653496]
291	Main KM, Skov M, Sillesen IB, et al. "Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient." Acta Paediatr 91 (2002): 1008-11. [PMID: 12412882]
292	Molimard M, Girodet PO, Pollet C, et al. "Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation." Drug Saf 31 (2008): 769-74. [PMID: 18707191]
293	Product Information. Entocort (budesonide). AstraZeneca Pharma Inc, Mississauga, ON.
294	Product Information. Incivek (telaprevir). Vertex Pharmaceuticals, Cambridge, MA.
295	Product Information. Victrelis (boceprevir). Schering-Plough Corporation, Kenilworth, NJ.
296	Raaska K, Niemi M, Neuvonen M, Neuvonen PJ, Kivisto KT "Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole." Clin Pharmacol Ther 72 (2002): 362-369. [PMID: 12386638]
297	Skov M, Main KM, Sillesen IB, Muller J, Koch C, Lanng S "Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide." Eur Respir J 20 (2002): 127-33. [PMID: 12166560]
298	Demolis JL, Vacheron F, Cardus S, Funck-Brentano C "Effect of single and repeated oral doses of telithromycin on cardiac QT interval in healthy subjects." Clin Pharmacol Ther 73 (2003): 242-52. [PMID: 12621389]
299	Product Information. Belbuca (buprenorphine). Endo Pharmaceuticals Solutions Inc, Malvern, PA.
300	Product Information. Buprenex (buprenorphine). Reckitt and Colman Pharmaceutical, Richmond, VA.
301	Product Information. Butrans (buprenorphine). Purdue Pharma LP, Stamford, CT.
302	Product Information. Ketek (telithromycin). Aventis Pharmaceuticals, Bridgewater, NJ.
303	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
304	European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products "European Public Assessment Report Ketek (telithromycin) (Rev. 2) ".
305	Product Information. Jevtana (cabazitaxel). sanofi-aventis , Bridgewater, NJ.
306	Product Information. Jardiance (empagliflozin). Boehringer Ingelheim, Ridgefield, CT.
307	Product Information. Vraylar (cariprazine). Actavis Pharma, Inc., Parsippany, NJ.
308	Agbin NE, Brater DC, Hall SD "Interaction of diltiazem with lovastatin and pravastatin." Clin Pharmacol Ther 61 (1997): 201. [PMID: 9797793]
309	Amsden GW, Kuye O, Wei GC "A study of the interaction potential of azithromycin and clarithromycin with atorvastatin in healthy volunteers." J Clin Pharmacol 42 (2002): 444-9. [PMID: 11936570]
310	Andreou ER, Ledger S "Potential drug interaction between simvastatin and danazol causing rhabdomyolysis." Can J Clin Pharmacol 10 (2003): 172-4. [PMID: 14712320]
311	Arnadottir M, Eriksson LO, Thysell H, Karkas JD "Plasma concentration profiles of simvastatin 3-hydroxy- 3-methylglutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without ciclosporin." Nephron 65 (1993): 410-3. [PMID: 8289991]
312	Ayanian JZ, Fuchs CS, Stone RM "Lovastatin and rhabdomyolysis." Ann Intern Med 109 (1988): 682-3. [PMID: 3421582]
313	Azie NE, Brater DC, Becker PA, Jones DR, Hall SD "The interaction of diltiazem with lovastatin and pravastatin." Clin Pharmacol Ther 64 (1998): 369-77. [PMID: 9797793]
314	Barry M, Mulcahy F, Merry C, Gibbons S, Back D "Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection." Clin Pharmacokinet 36 (1999): 289-304. [PMID: 10320951]
315	Campana C, Iacona I, Regassi MB, et al. "Efficacy and pharmacokinetics of simvastatin in heart transplant recipients." Ann Pharmacother 29 (1995): 235-9. [PMID: 7606066]
316	Chouhan UM, Chakrabarti S, Millward LJ "Simvastatin interaction with clarithromycin and amiodarone causing myositis." Ann Pharmacother 39 (2005): 1760-1. [PMID: 16159992]
317	Corpier CL, Jones PH, Suki WN, et al. "Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients." JAMA 260 (1988): 239-41. [PMID: 3290520]
318	Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, Bernini F "New insights into the pharmacodynamic and pharmacokinetic properties of statins." Pharmacol Ther 84 (1999): 413-28. [PMID: 10665838]
319	Dallaire M, Chamberland M "Severe rhabdomyolysis in a patient receiving lovastatin, danazol and doxycycline." Can Med Assoc J 150 (1994): 1991-4. [PMID: 8199978]
320	de Denus S, Spinler SA "Amiodarone's role in simvastatin-associated rhabdomyolysis." Am J Health Syst Pharm 60 (2003): 1791 author reply 1791-2. [PMID: 14503117]
321	Dresser GK, Spence JD, Bailey DG "Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition." Clin Pharmacokinet 38 (2000): 41-57. [PMID: 10668858]
322	East C, Alivizatos PA, Grundy SM, Jones PH, Farmer JA "Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation." N Engl J Med 318 (1988): 47-8. [PMID: 3275892]
323	Fichtenbaum CJ, Gerber JG, Rosenkranz SL, et al. "Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047." AIDS 16 (2002): 569-577. [PMID: 11873000]
324	Garnett WR "Interactions with hydroxymethylglutaryl-coenzyme A reductase inhibitors." Am J Health Syst Pharm 52 (1995): 1639-45. [PMID: 7583826]
325	Gilad R, Lampl Y "Rhabdomyolysis induced by simvastatin and ketoconazole treatment." Clin Neuropharmacol 22 (1999): 295-7. [PMID: 10516882]
326	Gruer PJK, Vega JM, Mercuri MF, Dobrinska MR, Tobert JA "Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin." Am J Cardiol 84 (1999): 811-5. [PMID: 10513779]
327	Grunden JW, Fisher KA "Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin." Ann Pharmacother 31 (1997): 859-63. [PMID: 9220046]
328	Gullestad L, Nordal KP, Berg KJ, Cheng H, Schwartz MS, Simonsen S "Interaction between lovastatin and cyclosporine A after heart and kidney transplantation." Transplant Proc 31 (1999): 2163-5. [PMID: 10456002]
329	Horn M "Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals." Arch Dermatol 132 (1996): 1254. [PMID: 8859048]
330	Huynh T, Cordato D, Yang F, et al. "HMG coA reductase-inhibitor-related myopathy and the influence of drug interactions." Intern Med J 32(9-10) (2002): 486-90. [PMID: 12380704]
331	Jacobson RH, Wang P, Glueck CJ "Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone." JAMA 277 (1997): 296. [PMID: 9002485]
332	Jacobson TA "Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors." Am J Cardiol 94 (2004): 1140-6. [PMID: 15518608]
333	Jardine A, Holdaas H "Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience." J Clin Pharm Ther 24 (1999): 397-408. [PMID: 10651972]
334	Jody DN "Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone." JAMA 277 (1997): 296-7. [PMID: 9002485]
335	Kantola T, Kivisto KT, Neuvonen PJ "Effect of itraconazole on cerivastatin pharmacokinetics." Eur J Clin Pharmacol 54 (1999): 851-5. [PMID: 10027660]
336	Kantola T, Kivisto KT, Neuvonen PJ "Effect of itraconazole on the pharmacokinetics of atorvastatin." Clin Pharmacol Ther 64 (1998): 58-65. [PMID: 9695720]
337	Kantola T, Kivisto KT, Neuvonen PJ "Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations." Clin Pharmacol Ther 64 (1998): 177-82. [PMID: 9728898]
338	Karnik NS, Maldonado JR "Antidepressant and statin interactions: a review and case report of simvastatin and nefazodone-induced rhabdomyolysis and transaminitis." Psychosomatics 46 (2005): 565-8. [PMID: 16288136]
339	Kivisto KT, Kantola T, Neuvonen PJ "Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin." Br J Clin Pharmacol 46 (1998): 49-53. [PMID: 9690949]
340	Kusus M, Stapleton DD, Lertora JJL, Simon EE, Dreisbach AW "Rhabdomyolysis and acute renal failure in a cardiac transplant recipient due to multiple drug interactions." Am J Med Sci 320 (2000): 394-7. [PMID: 11149552]
341	Lee AJ, Maddix DS "Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin." Ann Pharmacother 35 (2001): 26-31. [PMID: 11197581]
342	Lees RS, Lees AM "Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole." N Engl J Med 333 (1995): 664-5. [PMID: 7637734]
343	Lomaestro BM, Piatek MA "Update on drug interactions with azole antifungal agents." Ann Pharmacother 32 (1998): 915-28. [PMID: 9762380]
344	Malaty LI, Kuper JJ "Drug interactions of HIV protease inhibitors." Drug Safety 20 (1999): 147-69. [PMID: 10082072]
345	Maltz HC, Balog DL, Cheigh JS "Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine." Ann Pharmacother 33 (1999): 1176-9. [PMID: 10573315]
346	Mousa O, Brater DC, Sundblad KJ, Hall SD "The interaction of diltiazem with simvastatin." Clin Pharmacol Ther 67 (2000): 267-74. [PMID: 10741630]
347	Neuvonen PJ, Jalava KM "Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid." Clin Pharmacol Ther 60 (1996): 54-61. [PMID: 8689812]
348	Neuvonen PJ, Kantola T, Kivisto KT "Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole." Clin Pharmacol Ther 63 (1998): 332-41. [PMID: 9542477]
349	Norman DJ, Illingworth DR, Munson J, Hosenpud J "Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin." N Engl J Med 318 (1988): 46-7. [PMID: 3275891]
350	Omar MA, Wilson JP "FDA adverse event reports on statin-associated rhabdomyolysis." Ann Pharmacother 36 (2002): 288-95. [PMID: 11847951]
351	Paoletti R, Corsini A, Bellosta S "Pharmacological interactions of statins." Atheroscler Suppl 3 (2002): 35-40. [PMID: 12044584]
352	Product Information. Baycol (cerivastatin). Bayer, West Haven, CT.
353	Product Information. Lipitor (atorvastatin). Parke-Davis, Morris Plains, NJ.
354	Rodriguez JA, CrespoLeiro MG, Paniagua MJ, Cuenca JJ, Hermida LF, Juffe A, CastroBeiras A "Rhabdomyolysis in heart transplant patients on HMG-CoA reductase inhibitors and cyclosporine." Transplant Proc 31 (1999): 2522-3. [PMID: 10500698]
355	Roten L, Schoenenberger RA, Krahenbuhl S, Schlienger RG "Rhabdomyolysis in association with simvastatin and amiodarone." Ann Pharmacother 38 (2004): 978-81. [PMID: 15069169]
356	Siedlik PH, Olson SC, Yang BB, Stern RH "Erythromycin coadministration increases plasma atorvastatin concentrations." J Clin Pharmacol 39 (1999): 501-4. [PMID: 10234598]
357	Sipe BE, Jones RJ, Bokhart GH "Rhabdomyolysis Causing AV Blockade Due to Possible Atorvastatin, Esomeprazole, and Clarithromycin Interaction." Ann Pharmacother 37 (2003): 808-11. [PMID: 12773066]
358	Skrabal MZ, Stading JA, Monaghan MS "Rhabdomyolysis associated with simvastatin-nefazodone therapy." South Med J 96 (2003): 1034-5. [PMID: 14570351]
359	Spach DH, Bauwens JE, Clark CD, Burke WG "Rhabdomyolysis associated with lovastatin and erythromycin use." West J Med 154 (1991): 213-5. [PMID: 2006579]
360	Thompson M, Samuels S "Rhabdomyolysis with simvastatin and nefazodone." Am J Psychiatry 159 (2002): 1607. [PMID: 12202291]
361	Westphal JF "Macrolide - induced clinically relevant drug interactions with cytochrome P-450 (CYP) 3A4: an update focused on clarithromycin, azithromycin, and dirithromycin." Br J Clin Pharmacol 50 (2000): 285-95. [PMID: 11012550]
362	Williams D, Feely J "Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors." Clin Pharmacokinet 41 (2002): 343-70. [PMID: 12036392]
363	Wong PW, Dillard TA, Kroenke K "Multiple organ toxicity from addition of erythromycin to long-term lovastatin therapy." South Med J 91 (1998): 202-5. [PMID: 9496876]
364	Yeo KR, Yeo WW "Inhibitory effects of verapamil and diltiazem on simvastatin metabolism in human liver microsomes." Br J Clin Pharmacol 51 (2001): 461-70. [PMID: 11422004]
365	Yeo KR, Yeo WW, Wallis EJ, Ramsay LE "Enhanced cholesterol reduction by simvastatin in diltiazem-treated patients." Br J Clin Pharmacol 48 (1999): 610-5. [PMID: 10583033]
366	Zhou LX, Finley DK, Hassell AE, Holtzman JL "Pharmacokinetic interaction between isradipine and lovastatin in normal, female and male volunteers." J Pharmacol Exp Ther 273 (1995): 121-7. [PMID: 7714757]
367	Product Information. Lamprene (clofazimine). Novartis Pharmaceuticals, East Hanover, NJ.
368	Product Information. Cotellic (cobimetinib). Genentech, South San Francisco, CA.
369	Caraco Y, Sheller J, Wood AJJ "Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects." J Pharmacol Exp Ther 290 (1999): 413-22. [PMID: 10381807]
370	Caraco Y, Sheller J, Wood JJ "Pharmacogenetic determination of the effects of codeine and prediction of drug interactions." J Pharmacol Exp Ther 278 (1996): 1165-74. [PMID: 8819499]
371	Desmeules J, Dayer P, Gascon MP, Magistris M "Impact of genetic and environmental factors on codeine analgesia." Clin Pharmacol Ther 45 (1989): 122. [PMID: 1782973]
372	Desmeules J, Gascon MP, Dayer P, Magistris M "Impact of environmental and genetic factors on codeine analgesia." Eur J Clin Pharmacol 41 (1991): 23-6. [PMID: 1782973]
373	Hersh EV, Moore PA "Drug interactions in dentistry: the importance of knowing your CYPs." J Am Dent Assoc 135 (2004): 298-311. [PMID: 15058617]
374	Poulsen L, Brosen K, Srendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH "Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects." Eur J Clin Pharmacol 51 (1996): 289-95. [PMID: 9010701]
375	Sindrup SH, Arendt-Nielsen L, Brosen K, et al "The effect of quinidine on the analgesic effect of codeine." Eur J Clin Pharmacol 42 (1992): 587-92. [PMID: 1623898]
376	Sindrup SH, Brosen K, Bjerring P, et al. "Codeine increases pain threshold to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine." Clin Pharmacol Ther 49 (1991): 686-93. [PMID: 2249379]
377	Sindrup SH, Hofmann U, Asmussen J, Mikus G, Brosen K, Nielsen F, Ingwersen SH, Broen Christensen C "Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake." Eur J Clin Pharmacol 49 (1996): 503-9. [PMID: 8706777]
378	Thorn CF, Klein TE, Altman RB "Codeine and morphine pathway." Pharmacogenet Genomics 19 (2009): 556-8. [PMID: 19512957]
379	Vevelstad M, Pettersen S, Tallaksen C, Brors O "O-demethylation of codeine to morphine inhibited by low-dose levomepromazine." Eur J Clin Pharmacol 65 (2009): 795-801. [PMID: 19308365]
380	Zhou SF "Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II." Clin Pharmacokinet 48 (2009): 761-804. [PMID: 19902987]
381	Product Information. Aliqopa (copanlisib). Bayer Pharmaceutical Inc, West Haven, CT.
382	Product Information. Enablex (darifenacin). Novartis Pharmaceuticals, East Hanover, NJ.
383	Multum Information Services, Inc. Expert Review Panel.
384	Product Information. Cerubidine (daunorubicin). Wyeth-Ayerst Laboratories, Philadelphia, PA.
385	Product Information. Daunoxome (daunorubicin liposomal). Nexstar Pharmaceuticals Inc, Boulder, CO.
386	Product Information. Idamycin (idarubicin). Pharmacia and Upjohn, Kalamazoo, MI.
387	Funck-Brentano C, Jacqz-Aigrain E, Leenhardt A, Roux A, Poirier JM, Jaillon P "Influence of amiodarone on genetically determined drug metabolism in humans." Clin Pharmacol Ther 50 (1991): 259-66. [PMID: 1914360]
388	Product Information. Zytiga (abiraterone). Centocor Inc, Malvern, PA.
389	Ausband SC, Goodman PE "An unusual case of clarithromycin associated ergotism." J Emerg Med 4 (2001): 411-3. [PMID: 11728770]
390	Baldwin ZK, Ceraldi CC "Ergotism associated with HIV antiviral protease inhibitor therapy." J Vasc Surg 37 (2003): 676-8. [PMID: 12618710]
391	Bird PA, Sturgess AD "Clinical ergotism with severe bilateral upper limb ischaemia precipitated by an erythromycin - ergotamine drug interaction." Aust N Z J Med 30 (2000): 635-6. [PMID: 11108077]
392	Blanche P, Rigolet A, Gombert B, Ginsburg C, Salmon D, Sicard D "Ergotism related to a single dose of ergotamine tartrate in an AIDS patient treated with ritonavir." Postgrad Med J 75 (1999): 546-7. [PMID: 10616689]
393	Caballero-Granado FJ, Viciana P, Cordero E, Gomez-Vera MJ, del Nozal M, Lopez-Cortes LF "Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient." Antimicrob Agents Chemother 41 (1997): 1207. [PMID: 9145904]
394	Eadie MJ "Clinically significant drug interactions with agents specific for migraine attacks." Cns Drugs 15 (2001): 105-18. [PMID: 11460889]
395	Francis H, Tyndall A, Webb J "Severe vascular spasm due to erythromycin-ergotamine interaction." Clin Rheumatol 3 (1984): 243-6. [PMID: 6236021]
396	Hayton AC "Precipitation of acute ergotism by triacetyloleandomycin." N Z Med J 69 (1969): 42. [PMID: 5304704]
397	Horowitz RS, Dart RC, Gomez HF "Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction." Arch Intern Med 156 (1996): 456-8. [PMID: 8607732]
398	Leroy F, Asseman P, Pruvost P, Adnet P, Lacroix D, Thery C "Dihydroergotamine-erythromycin-induced ergotism." Ann Intern Med 109 (1988): 249. [PMID: 3389610]
399	Liaudet L "Severe ergotism associated with interaction between ritonavir and ergotamine." BMJ 318 (1999): 771. [PMID: 10082701]
400	Liaudet L, Buclin T, Jaccard C, Eckert P "Severe ergotism associated with interaction between ritonavir and ergotamine." Br Med J 318 (1999): 771. [PMID: 10082701]
401	Matthews NT, Havill JH "Ergotism with therapeutic doses of ergotamine tartrate." N Z Med J 89 (1979): 476-7. [PMID: 314074]
402	Montero A, Giovannoni AG, Tvrde PL "Leg ischemia in a patient receiving ritonavir and ergotamine." Ann Intern Med 130 (1999): 329. [PMID: 10068398]
403	Mortier E, Pouchet J, Vinceneux P, Lalande M "Ergotism related to interaction between nelfinavir and ergotamine." Am J Med 110 (2001): 594. [PMID: 11347624]
404	Product Information. Cafergot (caffeine-ergotamine). Novartis Pharmaceuticals, East Hanover, NJ.
405	Product Information. D.H.E. 45 (dihydroergotamine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
406	Product Information. Migranal (dihydroergotamine nasal). Novartis Pharmaceuticals, East Hanover, NJ.
407	Rosenthal E, Sala F, Chichmanian RM, Batt M, Cassuto JP "Ergotism related to concurrent administration of ergotamine tartrate and indinavir." JAMA 281 (1999): 987. [PMID: 10086430]
408	Spiegel M, Schmidauer C, Kampfl A, Sarcletti M, Poewe W "Cerebral ergotism under treatment with ergotamine and ritonavir." Neurology 57 (2001): 743-4. [PMID: 11524501]
409	Srisuma S, Lavonas EJ, Wananukul W "Ergotism and factitious hypotension associated with interaction of ergotamine with CYP3A4 inhibitors." Clin Toxicol (Phila) (2014): 1-4. [PMID: 24978905]
410	Tribble MA, Gregg CR, Margolis DM, Amirkhan R, Smith JW "Fatal ergotism induced by an HIV protease inhibitor." Headache 42 (2002): 694-5. [PMID: 12482227]
411	Vila A, Mykietiuk A, Bonvehi P, Temporiti E, Uruena A, Herrera F "Clinical ergotism induced by ritonavir." Scand J Infect Dis 33 (2001): 788-9. [PMID: 11728055]
412	Ghali R, De Lean J, Douville Y, Noel HP, Labbe R "Erythromycin-associated ergotamine intoxication: arteriographic and electrophysiologic analysis of a rare cause of severe ischemia of the lower extremities and associated ischemic neuropathy." Ann Vasc Surg 7 (1993): 291-6. [PMID: 8391300]
413	Aronson JK, Grahame-Smith DG "Clinical pharmacology: adverse drug interactions." Br Med J 282 (1981): 288-91. [PMID: 6779990]
414	Engels FK, Mathot RA, Loos WJ, van Schaik RH, Verweij J "Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel." Cancer Biol Ther 5 (2006): 833-9. [PMID: 16775418]
415	McInnes GT, Brodie MJ "Drug interactions that matter: a critical reappraisal." Drugs 36 (1988): 83-110. [PMID: 3063497]
416	Product Information. Taxotere (docetaxel). Rhone-Poulenc Rorer, Collegeville, PA.
417	Starr SP, Hammann F, Gotta V, et al. "Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity." Br J Clin Pharmacol 450 (2016): 22-27. [PMID: 27868228]
418	Vodovar D, Arnaout M, Mongardon N, et al. "Severe docetaxel overdose induced by pharmacokinetic interaction with dronedarone." J Clin Oncol 29 (2011): e694-5. [PMID: 21730272]
419	Yong WP, Wang LZ, Tham LS, et al. "A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers." Cancer Chemother Pharmacol 62 (2008): 243-51. [PMID: 17909805]
420	Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
421	Skinner MH, Kuan HY, Pan A, et al. "Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers." Clin Pharmacol Ther 73 (2003): 170-7. [PMID: 12621382]
422	Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
423	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
424	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
425	Product Information. Balversa (erdafitinib). Janssen Products, LP, Horsham, PA.
426	Product Information. Halaven (eribulin). Eisai Inc, Teaneck, NJ.
427	Product Information. Afinitor (everolimus). Novartis Pharmaceuticals, East Hanover, NJ.
428	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
429	Pierce DA, Reeves-Daniel AM "Ranolazine-tacrolimus interaction." Ann Pharmacother 44 (2010): 1844-9. [PMID: 20876828]
430	Product Information. Toviaz (fesoterodine). Pfizer U.S. Pharmaceuticals Group, New York, NY.
431	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
432	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
433	Product Information. Accolate (zafirlukast). Zeneca Pharmaceuticals, Wilmington, DE.
434	Product Information. Zepatier (elbasvir-grazoprevir). Merck &amp Company Inc, Whitehouse Station, NJ.
435	Product Information. Intuniv (guanfacine). Shire US Inc, Florence, KY.
436	Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
437	Corona G, Vaccher E, Sandron S, et al. "Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma." Clin Pharmacol Ther 83 (2008): 601-6. [PMID: 17713471]
438	Phansalker S, Desai AA, Bell D, et al "High-priority drug-drug interactions for use in electronic health records." J Am Med Inform Assoc 19 (2012): 735-43. [PMID: 22539083]
439	Product Information. Camptosar (irinotecan). Pharmacia and Upjohn, Kalamazoo, MI.
440	Product Information. Onivyde (irinotecan liposomal). Merrimack Pharmaceuticals, Cambridge, MA.
441	Product Information. Reyvow (lasmiditan). Lilly, Eli and Company, Indianapolis, IN.
442	Product Information. Lucemyra (lofexidine). US WorldMeds LLC, Louisville , KY.
443	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
444	Eggleston W, Clark KH, Marraffa JM "Loperamide abuse associated with cardiac dysrhythmia and death." Ann Emerg Med 69 (2017): 83-6. [PMID: 27140747]
445	US Food and Drug Administration "FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse.".
446	Product Information. Caplyta (lumateperone). Intra-Cellular Therapies, Inc., New York, NY.
447	Product Information. Latuda (lurasidone). Sunovion Pharmaceuticals Inc, Marlborough, MA.
448	Product Information. Zepzelca (lurbinectedin). Jazz Pharmaceuticals, Palo Alto, CA.
449	Product Information. Opsumit (macitentan). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
450	Product Information. Selzentry (maraviroc). Pfizer U.S. Pharmaceuticals Group, New York, NY.
451	Product Information. ORAVIG (miconazole). Strativa Pharmaceuticals, a Division of Par Pharmaceuticals, Inc., Woodcliff Lake, NJ.
452	Product Information. Remeron (mirtazapine). Organon, West Orange, NJ.
453	Product Information. Symproic (naldemedine). Shionogi USA Inc, Florham Park, NJ.
454	Product Information. Ofev (nintedanib). Boehringer Ingelheim, Ridgefield, CT.
455	Fuhr U, Maier-Bruggemann A, Blume H, et al. "Grapefruit juice increases oral nimodipine bioavailability." Int J Clin Pharmacol Ther 36 (1998): 126-32. [PMID: 9562227]
456	Gunston GD, Mehta U "Potentially serious drug interactions with grapefruit juice." S Afr Med J 90 (2000): 41. [PMID: 10721388]
457	Product Information. Sodium Nitrite (sodium nitrite). Hope Pharmaceuticals, Scottsdale, AZ.
458	Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
459	Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
460	Product Information. Ibrance (palbociclib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
461	Product Information. Pemazyre (pemigatinib). Incyte Corporation, Wilmington, DE.
462	Product Information. Trental (pentoxifylline). Hoechst Marion-Roussel Inc, Kansas City, MO.
463	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
464	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
465	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
466	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
467	Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
468	Product Information. Esbriet (pirfenidone). Intermune Inc, Brisbane, CA.
469	Product Information. Wakix (pitolisant). Harmony Biosciences, LLC, Plymouth Meeting, PA.
470	Product Information. Polivy (polatuzumab vedotin). Genentech, South San Francisco, CA.
471	Product Information. Gavreto (pralsetinib). Blueprint Medicines Corporation, Cambridge, MA.
472	Hanci V, Aydin M, Yurtlu BS, et.al "Anesthesia induction with sevoflurane and propofol: evaluation of P-wave dispersion, QT and corrected QT intervals." Kaohsiung J Med Sci 26 (2010): 470-7. [PMID: 20837343]
473	Kim DH, Kweon TD, Nam SB, Han DW, Cho WY, Lee JS "Effects of target concentration infusion of propofol and tracheal intubation on QTc interval." Anaesthesia 63 (2008): 1061-4. [PMID: 18717665]
474	Kleinsasser A, Kuenszberg E, Loeckinger A, et.al "Sevoflurane, but not propofol, significantly prolongs the Q-T interval." Anesth Analg 90 (2000): 25-7. [PMID: 10624970]
475	Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F "Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol." Anaesthesia 56 (2001): 248-50. [PMID: 11251432]
476	Paventi S, Santevecchi A, Ranieri R "Effects of sevoflurane versus propofol on QT interval." Minerva Anestesiol 67 (2001): 637-40. [PMID: 11731753]
477	Scalese MJ, Herring HR, Rathburn RC, Skrepnek GH, Ripley TL "Propofol-associated QTc prolongation." Ther Adv Drug Saf 7 (2016): 68-78. [PMID: 27298717]
478	Staikou C, Stamelos M, Stavroulakis E "Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity." Br J Anaesth 112 (2014): 217-30. [PMID: 24305646]
479	Toyoda T, Terao Y, Oji M, Okada M, Fukusaki M, Sumikawa K "The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction." J Anesth 27 (2013): 885-9. [PMID: 23660990]
480	Whyte SD, Booker PD, Buckley DG "The Effects of Propofol and Sevoflurane on the QT Interval and Transmural Dispersion of Repolarization in Children." Anesth Analg 100 (2005): 71-77. [PMID: 15616054]
481	Wutzler A, De Asmundis C, Matsuda H, et.al "Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults." J Electrocardiol 51 (2018): 170-4. [PMID: 29174097]
482	Product Information. Nurtec ODT (rimegepant). Biohaven Pharmaceuticals, New Haven, CT.
483	Product Information. Adempas (riociguat). Bayer Pharmaceutical Inc, West Haven, CT.
484	Product Information. Qinlock (ripretinib). Deciphera Pharmaceuticals, Waltham, MA.
485	Product Information. Xarelto (rivaroxaban). Bayer Inc, Toronto, IA.
486	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
487	Product Information. Exelon (rivastigmine) Novartis Pharmaceuticals, East Hanover, NJ.
488	Product Information. Razadyne (galantamine). Johnson and Johnson Medical Inc, Arlington, TX.
489	Product Information. Koselugo (selumetinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
490	Product Information. Rapaflo (silodosin). Watson Pharmaceuticals, Corona, CA.
491	Product Information. Zorbtive (somatropin). Serono Laboratories Inc, Rockland, MA.
492	Product Information. Humatrope (somatropin). Lilly, Eli and Company, Indianapolis, IN.
493	Product Information. Odomzo (sonidegib). Novartis Pharmaceuticals, East Hanover, NJ.
494	Product Information. Nexavar (sorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
495	Product Information. Diacomit (stiripentol). Biocodex Inc, Creswell, OR.
496	Product Information. Talzenna (talazoparib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
497	Franco-Salinas G, de la Rosette JJ, Michel MC "Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations." Clin Pharmacokinet 49 (2010): 177-88. [PMID: 20170206]
498	Kamimura H, Oishi S, Matsushima H, et al. "Identification of cytochrome P450 isozymes involved in metabolism of the alpha1-adrenoceptor blocker tamsulosin in human liver microsomes." Xenobiotica 28 (1998): 909-22. [PMID: 9849639]
499	Product Information. Flomax (tamsulosin). Boehringer-Ingelheim, Ridgefield, CT.
500	Product Information. Xermelo (telotristat ethyl). Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
501	Product Information. Myoview (tetrofosmin). GE Healthcare, Princeton, NJ.
502	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
503	Edeki TI, He HB, Wood AJJ "Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops: potential for oral-ophthalmic drug interaction." JAMA 274 (1995): 1611-3. [PMID: 7474246]
504	Fraunfelder FT, Fraunfelder FW Randall JA "Drug-Induced Ocular Side Effects 5th" Boston, MA: Butterworth-Heinemann (2001):.
505	Lewis RV, Lennard MS, Jackson PR, Tucker GT, Ramsay LE, Woods HF "Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics." Br J Clin Pharmacol 19 (1985): 329-33. [PMID: 2859048]
506	Product Information. Samsca (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
507	Machiels JP, Staddon A, Herremans C, et al. "Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studies." Cancer Chemother Pharmacol 74 (2014): 729-37. [PMID: 25100135]
508	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
509	Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5. [PMID: 15792261]
510	Dattilo PB, Nordin C "Prolonged QT associated with an overdose of trazodone." J Clin Psychiatry 68 (2007): 1309-10. [PMID: 17854263]
511	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
512	Levenson JL "Prolonged QT interval after trazodone overdose." Am J Psychiatry 156 (1999): 969-70. [PMID: 10360146]
513	Mazur A, Strasberg B, Kusniec J, Sclarovsky S "QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination." Int J Cardiol 52 (1995): 27-9. [PMID: 8707432]
514	Product Information. Oleptro (traZODone). Labopharm Inc, Laval, AL.
515	Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
516	FDA. U.S. Food and Drug Administration "Drug Safety Communications: FDA updates label for stop smoking drug Chantix (varenicline) to include potential alcohol interaction, rare risk of seizures, and studies of side effects on mood, behavior, and thinking. Safety announcement." .
517	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
518	Hyland R, Roe GH, Jones BC, Smith DA "Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil." Br J Clin Pharmaacol 51 (2001): 239-48. [PMID: 11298070]
519	Product Information. Revatio (sildenafil). Pfizer U.S. Pharmaceuticals Group, New York, NY.
520	Product Information. Viagra (sildenafil). Pfizer US Pharmaceuticals, New York, NY.
521	Warrington JS, Shader RI, vonMoltke LL, Greenblatt DJ "In vitro biotransformation of sildenafil (Viagra): Identification of human cytochromes and potential drug interactions." Drug Metab Disposition 28 (2000): 392-7. [PMID: 10725306]
522	Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
523	Rojas-Fernandez C, Fisher C "Drug interactions and donepezil." J Am Geriat Soc 40 (2000): 597-8. [PMID: 10811561]
524	Tiseo PJ, Perdomo CA, Friedhoff LT "Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses." Br J Clin Pharmacol 46 (1998): 30-4. [PMID: 9839763]
525	Product Information. Pifeltro (doravirine). Merck & Company Inc, Whitehouse Station, NJ.
526	Product Information. Dificid (fidaxomicin). Optimer Pharmaceuticals, San Diego, CA.
527	Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F "QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone." Pacing Clin Electrophysiol 28 (2005): 472-3. [PMID: 15869686]
528	Product Information. Flagyl (metronidazole). Searle, Skokie, IL.
529	Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN). Aptalis Pharma, Birmingham, AL.
530	Product Information. Movantik (naloxegol). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
531	Product Information. Elidel (pimecrolimus topical). Novartis Pharmaceuticals, East Hanover, NJ.
532	Ekstrom G, Gunnarsson UB "Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes." Drug Metab Dispos 24 (1996): 955-61. [PMID: 8886604]
533	Halldin MM, Bredberg E, Angelin B, Arvidsson T, Askemark Y, Elofsson S, Widman M "Metabolism and excretion of ropivacaine in humans." Drug Metab Dispos 24 (1996): 962-8. [PMID: 8886605]
534	Jokinen MJ, Ahonen J, Neuvonen PJ, Olkkola KT "The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine." Anesth Analg 91 (2000): 1207-12. [PMID: 11049910]
535	McClure JH "Ropivacaine." Br J Anaesth 76 (1996): 300-7. [PMID: 8777115]
536	Oda Y, Furuichi K, Tanaka K, Hiroi T, Imaoka S, Asada A, Fujimori M, Funae Y "Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450." Anesthesiology 82 (1995): 214-20. [PMID: 7832304]
537	Product Information. Naropin (ropivacaine). Astra USA, Westborough, MA.
538	Arlander E, Ekstrom G, Alm C, Carrillo JA, Bielenstein M, Bottiger Y, Bertilsson L, Gustafsson LL "Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors." Clin Pharmacol Ther 64 (1998): 484-91. [PMID: 9834040]
539	Product Information. Jakafi (ruxolitinib). Incyte Corporation, Wilmington, DE.
540	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]
541	Darpo B "Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes." Eur Heart J Suppl 3(Suppl K) (2001): K70-80.
542	Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T "QT prolongation and torsades de pointes after administration of trimethoprin-sulfamethoxazole." Am J Cardiol 59 (1987): 376-7. [PMID: 3492908]
543	Wiener I, Rubin D, Martinez E, et al "QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration." Mt Sinai J Med 48 (1981): 53-5. [PMID: 6970886]
544	Brynne N, Svanstrom C, AbergWistedt A, Hallen B, Bertilsson L "Fluoxetine inhibits the metabolism of tolterodin-pharmacokinetic implications and proposed clinical relevance." Br J Clin Pharmacol 48 (1999): 553-63. [PMID: 10583026]
545	Product Information. Detrol (tolterodine). Pharmacia and Upjohn, Kalamazoo, MI.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence